WO1999012950A2 - Improvements in or relating to stability of plant starches - Google Patents

Improvements in or relating to stability of plant starches Download PDF

Info

Publication number
WO1999012950A2
WO1999012950A2 PCT/GB1998/002665 GB9802665W WO9912950A2 WO 1999012950 A2 WO1999012950 A2 WO 1999012950A2 GB 9802665 W GB9802665 W GB 9802665W WO 9912950 A2 WO9912950 A2 WO 9912950A2
Authority
WO
WIPO (PCT)
Prior art keywords
plant
starch
sequence
nucleic acid
isoamylase
Prior art date
Application number
PCT/GB1998/002665
Other languages
French (fr)
Other versions
WO1999012950A3 (en
WO1999012950A9 (en
Inventor
Stephen Alan Jobling
Gerhard Peter Schwall
Roger John Westcott
Original Assignee
National Starch And Chemical Investment Holding Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Starch And Chemical Investment Holding Corporation filed Critical National Starch And Chemical Investment Holding Corporation
Priority to CA002302639A priority Critical patent/CA2302639A1/en
Priority to AU89911/98A priority patent/AU8991198A/en
Priority to EP98941593A priority patent/EP1009751A2/en
Publication of WO1999012950A2 publication Critical patent/WO1999012950A2/en
Publication of WO1999012950A3 publication Critical patent/WO1999012950A3/en
Publication of WO1999012950A9 publication Critical patent/WO1999012950A9/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2451Glucanases acting on alpha-1,6-glucosidic bonds
    • C12N9/2457Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2451Glucanases acting on alpha-1,6-glucosidic bonds
    • C12N9/246Isoamylase (3.2.1.68)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01041Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01068Isoamylase (3.2.1.68)

Definitions

  • This invention relates to novel nucleotide sequences, nucleic acid constructs and host cells and organisms comprising said sequences, methods of altering plants using the sequences, and to products obtainable from the altered plants.
  • Starch the major storage reserve in plants, consists of two main polysaccharides, amylose and amylopectin.
  • Amylose is a linear polymer containing ⁇ -1,4 linked glucose units
  • amylopectin is a highly branched polymer consisting of a ⁇ -1,4 linked glucan backbone with ⁇ -1,6 linked glucan branches.
  • amylopectin constitutes about 75% of the starch content.
  • starch synthases which elongate the glucan chains
  • SBE starch branching enzymes
  • Debranching enzymes hydrolyse the ⁇ l-6-glucosidic linkages of ⁇ -glucan polymers and are classified into two types depending on their substrate specificities: (1) pullulanases (EC 3.2.1.41 , which are known in plants as "R- enzymes") which act on amylopectin and puUulan (a linear bacterial polymer consisting of 1-6 linked maltotriose units) but which cannot use glycogen as a substrate; and (2) isoamylases (EC 3.2.1.68) which act on amylopectin and glycogen but cannot use puUulan as a substrate.
  • pullulanases EC 3.2.1.41 , which are known in plants as "R- enzymes”
  • puUulan a linear bacterial polymer consisting of 1-6 linked maltotriose units
  • Pullulanases have been purified from a number of plants including maize, rice, sorghum, oat, broad bean, potato, sugarbeet and spinach and the corresponding cDNA clones of maize, rice and spinach have been isolated (James et al 1995; Nakamura et al 1996; Renz et al 1995). In potato, both R-enzyme and isoamylase enzyme polypeptides have been characterised and purified (Drummond et al 1970; Ishizaki,Y et al 1983). A recent publication (WO 95/04826) detailed the purification and peptide sequence determination of a pullulanase type DBE.
  • a cDNA encoding a potato DBE was described in a second patent application (WO 96/19581) which detailed the isolation of a partial length (492 bp) cDNA clone encoding a pullulanase type DBE, as well as the effect of downregulating the expression of this gene in transgenic antisense plants.
  • An unspecified number of lines were generated and some showed a decrease in debranching enzyme activity (not quantitated) which also led to a slight modification in the swelling characteristics of the starch as measured by RVA (Rapid Viscoamylograph).
  • the present application relates particularly to the isolation of nucleic acid sequences encoding potato debranching enzymes (especially isoamylase type debranching enzymes) and to the uses thereof.
  • the invention provides a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene.
  • DBE isoamylase-type debranching enzyme
  • the nucleic acid sequence will comprise at least one region which is characteristic of isoamylase-type debranching enzymes and which is not present in pullulanase type debranching enzymes.
  • the nucleic acid sequence will preferably be at least 200bp long, more preferably at least 300-600bp long. Conveniently the sequence is one which is derived or obtained from potato plants.
  • the nucleic acid sequence of the invention may be, for instance, a genomic sequence, or may be a cDNA sequence.
  • the nucleic acid sequence of the invention may comprise non- coding portions (which are transcribed, but not translated), and/or may comprise coding portions, which are translated into amino acid residues in the full length native gene. As described below, either translated or non-translated portions may be useful in certain techniques, and both therefore possess utility.
  • the nucleic acid sequence comprises nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8, or a functional equivalent thereof.
  • This sequence includes a portion encoding the amino acid sequence MDWF/YNH, which portion is typically present in the nucleic acid sequences of the invention.
  • Functionally equivalent nucleic acid sequences include sequences which encode substantially the same polypeptide, but which differ in nucleotide sequence from mat shown in Figure 8 by virtue of the degeneracy of the genetic code.
  • a nucleic acid sequence may be altered (e.g.
  • nucleotide sequence differs substantially whilst the amino acid sequence of the encoded polypeptide is unchanged.
  • functionally equivalent nucleic acid sequences are those- which will hybridise under stringent hybridisation -conditions (e.g..as- described by Sambrook et al, Molecular Cloning. A Laboratory Manual, CSH, i.e. washing with O. lxSSC, 0.5% SDS at 68°C) with the sequence shown in Figure 8.
  • Figures_6A-7B illustrate some related sequences, which are also in accordance with the present invention. These are genomic sequences with large stretches of intron sequence, which introns are not represented in rnRNA. The sequences illustrated in Figures 6A-7B thus comprise both coding and non-coding portions.
  • DNA sequences functionally equivalent to that shown in Figure 8 will preferably comprise at least 200, more preferably 300-600bp, and typically will exhibit at least 85% identity (preferably at least 90%, and more preferably at least 95% identity) with the corresponding region of the DNA sequence shown in Figure 8.
  • Those skilled in the an will readily be able to conduct a sequence alignment between the putative functionally equivalent sequence and that detailed in Figure 8 - the identity of the two sequences is to be compared in those regions which are aligned by standard computer software, which aligns corresponding regions of the sequences.
  • the invention provides a replicable nucleic acid construct comprising the nucleic acid sequence of the first aspect defined above.
  • the construct may typically comprise a selectable marker (e.g. kanamycin or hygromycin-resistance) and may allow for transcription (and possibly translation) of the nucleic acid sequence of the invention.
  • a selectable marker e.g. kanamycin or hygromycin-resistance
  • the construct will comprise a promoter (especially a promoter sequence operable in a plant and/or a promoter operable in a bacterial cell), and one or more regulatory signals (such as polyadenylation signals) known to those skilled in the art.
  • the nucleic acid sequence of the invention can be introduced into plants which express a homologous sequence encoding an isoamylase enzyme, in such a way that the introduced sequence interferes with the expression of the homologous sequence.
  • the nucleic acid sequence of the invention may be operably linked in the antisense orientation to a suitable promoter active in the plant into which the sequence is to be introduced, so as to reduce the levels of expression of the homologous isoamylase enzyme present in the plant-. _ -
  • sense suppression can also occur (i.e. expression of an introduced sequence operably linked in the sense orientation can interfere, by some unknown mechanism, with the expression of the homologous, native gene), as described by Matzke & Matzke (1995 Plant Physiol. 107, 679-685). Any one of the methods mentioned by Matzke & Matzke could, in theory, be used to affect the expression in a host of a homologous isoamylase gene.
  • antisense methods are mainly operable by the production of antisense mRNA which hybridises to the sense mRNA, preventing its translation into functional polypeptide, possibly by causing the hybrid RNA to be degraded (e.g. Sheehy et al, 1988 PNAS 55, 8805-8809; Van der Krol et al, Mol. Gen. Genet. 220, 204-212).
  • Sense suppression also requires homology between the introduced sequence and the target gene, but the exact mechanism is unclear.
  • nucleic acid used will comprise at least 300-600bp of sequence, but by simple trial and error other fragments (smaller or larger) may be found which are functional in altering the characteristics of the plant.
  • the invention provides a method of altering a plant by inhibiting the expression of an isoamylase gene therein, the method comprising introducing into the plant the nucleic acid sequence of the invention, operably linked (in the sense or anti-sense orientation) to a promoter active in the plant, wherein the isoamylase gene in the plant has homology to the introduced sequence.
  • the introduced nucleic acid will typically comprise at least 200bp, more preferably 300-600bp of sequence having at least 80% (advantageously at least 85%, desirably over 90%) sequence identity with the native isoamylase gene(s) present in the plant.
  • the " plant will be a plant which normally comprises large amounts oi J starch, such as potato, sweet potato, maize, wheat, barley, oat, cassava, pea, rice and the like. It is probable that the greater the homology between the introduced sequence and the native gene, the greater the inhibition of expression of the native gene.
  • the plant is therefore a potato plant, and/or a plant which has a reduced amylose content (e.g. the "waxy” mutation of potato or the "LAM” [low amylose mutant] strain of pea).
  • Inhibition of the isoamylase gene might be expected to affect the properties of the starch present in the plant. In particular it might be expected to result in a starch having increased branching and/or shorter chain length. The obtaining of starch having such properties is a particular object of the present invention.
  • nucleic acid sequences may also be advantageous to introduce into the plant one or more additional nucleic acid sequences, especially sequences which might also be expected to have an effect on synthesis and/or metabolism of starch in the plant.
  • Particularly preferred are sequences which inhibit the expression of a pullulanase debranching enzyme in the plant.
  • Plant pullulanase sequences are known to those skilled in the art (e.g. WO 96/19581), and a portion of a potato pullulanase cDNA sequence is also disclosed herein.
  • the additional nucleic acid sequence will typically be homologous to a portion of a native gene in the plant and, as described above, may be introduced into the plant operably linked to a suitable promoter in either the sense or the anti-sense orientation.
  • the introduced sequence of the invention and the one or more additional sequences may be operably linked to a single promoter (which would ensure both sequences were transcribed at essentially the same time), or may be operably linked to separate promoters (which may be necessary for optimal expression). Where separate promoters are employed they may be identical to each other or different. Suitable promoters are well known to those skilled in the art and include both constitutive and inducible types. Examples include the CaMV 35S promoter (e.g. single or tandem repeat) and the GBSS type I or patatin promoters of potato.
  • the promoter will be tissue-specific. Desirably the promoter will cause expression of the operably linked sequence at substantial levels only in the tissue of the plant where starch synthesis and/or starch storage mainly occurs. Thus, for " example, where the sequence is introduced into a potato plant, the * operably linked promoter may be tuber-specific, such as the patatin promoter.
  • nucleic acid sequences may be present on the same nucleic acid plant transformation vector as the portion of isoamylase-encoding sequence, or may be introduced on separate vectors (for example by re-transformation).
  • sequence of the invention, and the one or more additional sequences if desired, can be introduced into the plant by any one of a number of well-known techniques (e.g. Agrobacterium-mediated transformation, or by "biolistic" methods).
  • the invention provides a plant cell, or a plant or the progeny thereof, which has been altered by the method defined above.
  • Altered plant cells, into which the sequence of the invention has been introduced may be grown into plantlets by conventional methods well-known to those skilled in the an.
  • the progeny of an altered plant may be obtained, for example, by vegetative propagation, or by crossing the altered plant and reserving the seed so obtained.
  • the invention also provides pans of the altered plant, such as storage organs.
  • the invention provides tubers comprising altered starch, said tubers being obtained from an altered plant or the progeny thereof.
  • the invention also provides a method of obtaining starch from an altered plant, the plant being obtained by the method defined above.
  • Starch may be extracted from the plant by any of the known techniques (e.g. milling).
  • the invention further provides starch obtainable from a plant altered by the method defined above, the starch having altered propenies compared to starch extracted from an equivalent but unaltered plant.
  • the altered starch is obtained from an altered plant selected from the group consisting of cassava, potato, pea, tomato, maize, wheat, barley, oat, sweet potato and rice.
  • the altered starch will have an increased degree of branching and/or reduced amylopectin chain length, compared to starch extracted from an equivalent but unaltered plant.
  • such altered starch obtained by means of the present invention is found to possess different viscosity charcteristics compared to starch extracted from equivalent, but unaltered, plants.
  • the inventors have found that starch obtained from plants altered by the method of the invention may have reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument, (available from Newport Scientific, Sydney, Australia) according to the manufacturer's standard stirring and heating protocol.
  • the altered starch may have higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, (as determined, for example, by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument). Further, the altered starch may have an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, (as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument).
  • peak viscosity is well known and understood by the person skilled in the art.
  • the viscosity of starch preparations is generally investigated by heating an aqueous sample of the starch under controlled conditions of temperature increase, temperature maintenance, and subsequent temperature decrease and with controlled stirring, using an instrument known as a Visco analyser, which produces a viscosity profile called a "viscoamylograph".
  • the "peak viscosity” is the maximum viscosity which is attained during the temperature increase phase.
  • setback viscosity is the viscosity obtained at the end of the viscoamylograph.
  • the viscosity onset temperature is the temperature at which a sudden increase of viscosity is apparent on the viscoamylograph.
  • an "equivalent, but unaltered” plant may be considered as a plant which has a substantially identical genotype to a plant altered by the method of the invention, except for the introduced sequences present in the altered plant of the invention. Also to be considered as an equivalent but unaltered plant are those plants which comprise the introduced sequence but wherein the introduced sequence has not affected the starch properties of the plant.
  • the invention provides a nucleic acid sequence encoding at least a portion of a potato pullulanase type debranching enzyme, the sequence comprising- substantially nucleotides 46-774 of the nucleic acid sequence shown in Figure 10, or a functional equivalent thereof.
  • the term "functional equivalent” should be interpreted as explained previously, but with reference (in this aspect of the invention) to Figure 10 rather than Figure 8.
  • the invention provides nucleic acid constructs, and altered host plant cells and organisms, comprising the pullulanase-type DBE nucleic acid sequence defined immediately above.
  • Figure 1 shows a comparison of the known amino acid sequences of various putative isoamylase proteins.
  • the shaded area indicates residues (single letter amino acid code) that are identical to the maize protein. Dashes indicate gaps introduced to maximise the alignment. Although the whole sequences were compared, only the most conserved region is shown. Sequences are identified at the right; A10906_l is an artificial sequence, A37035 is from a Pseudomonas species SMP1, HIU32761 is from Haemophilus influenzae, ISOA_PSESP is from Pseudomonas amylodermosa and ZMU18908_1 is from Zea mays (corn);
  • Figures 2A and 2B show a comparison of the 5' and 3' ends (respectively) of two partial pullulanase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
  • Figures 3A and 3B show the DNA sequence (SEQ. ID. NO.s 1 and 4 respectively) and predicted intron exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 2 and 3) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
  • Figures 4A and 4B show the DNA sequence (SEQ. ID. NO.s 5 and 8 respectively) and- predicted intron/exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 6 and 7) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
  • Figures 5 A and 5B show a comparison of the 5' and 3' ends (respectively) of two partial isoamylase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
  • Figures 6 A and 6B show the DNA sequence (SEQ. ID. NO.s 9 and 11 respectively) and predicted intron/exon strucmre, including predicted amino acid sequence (SEQ. ID. NO. 10) at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
  • Figures 7A and 7B show the DNA sequence (SEQ. ID. NO.s 12 and 13 respectively) and predicted intron/exon strucmre at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
  • Figure 8 shows the DNA sequence (SEQ. ID. NO. 14), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 15) of a partial length potato debranching enzyme (isoamylase) cDNA clone (pSJ132, described below); nucleotides 79-1595, including the poly(A) tail, are isoamylase, the other sequence is derived from pT7Blue vector;
  • Figure 9 is a schematic representation of the plant transformation vector pSJ138.
  • Figure 10 shows the DNA sequence (SEQ. ID. NO. 16), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 17) of a pullulanase type partial length potato debranching enzyme cDNA clone (pSJ98, described below); nucleotides 46-774 are DBE, the other sequence is derived from pT7Blue vector;
  • Figure 11 is a schematic representation of a "double" plant transformation vector, comprising partial isoamylase- and pullulanase-type debranching enzyme sequences operably linked in the anti-sense orientation to separate GBSS promoters;
  • Figure 12 shows a zymogram (using a 5% polyacrylamide gel containing 1 % amylopectin) of mber extracts from potato lines transformed with an antisense isoamylase construct in accordance with the invention.
  • Figure 13 shows viscosity (RVA) profiles of starch from potato lines transformed with an antisense isoamylase construct, and from a wild type control (1302).
  • Example 1 Isolation of a partial cDNA clone of a potato isoamylase.
  • PDBE2 ATC AAA TCT/G A/GAA nCC ATC DBE1 ATG GAT GTT GT(T/C/A) TA/TC/T AAT/C CAT
  • Genomic DNA was isolated from potato leaves using a modified CTAB (cetyltrimethyl ammonium bromide) method (Murray and Thompson, 1980).
  • Leaf tissue (4 gm) was frozen in liquid nitrogen and ground in a mortar and pestle and transferred to a 50 ml polypropylene centrifuge tube (Falcon) to which was added 40 ml of extraction buffer ( 2% w/v CTAB, 100 mM Tris-HCl pH 8.0, 1.4 M NaCl, 10 mM 3-mercaptoefhanol and 20 mM EDTA) and incubated at 65°C for 30 min.
  • extraction buffer 2% w/v CTAB, 100 mM Tris-HCl pH 8.0, 1.4 M NaCl, 10 mM 3-mercaptoefhanol and 20 mM EDTA
  • the mixture was split into two tubes and 15 ml of chloroform was added to each followed by gentle (end over end) mixing for 15 min at room temperature.
  • the tubes were then centrifuged for 5 min at 5000g and the pooled aqueous phases were re-extracted with 5 ml of chloroform.
  • the DNA was then precipitated by incubating on ice for 30 minutes with an equal volume of isopropanol and centrifuged for 5 minutes at 3000g. The pellet was washed once with 70% ethanol, briefly air-dried and resuspended in TE pH 8.0 containing 20 ⁇ g ml RNase A.
  • the DNA was extracted with 5ml of chloroform, one tenth volume of 3 M sodium acetate (NaAc) pH 5.2 was added and the DNA precipitated with two volumes of ethanol. After centrifugation and washing as above, the DNA was resuspended in 2 ml of TE buffer at pH 8.0 and estimated to be approximately 150 ng/ ⁇ l by fluorometric measurement.
  • oligonucleotide primers were made corresponding to these sequences (DBE2 & DBE1 respectively, see above), taking into consideration the codon usage in plant genes in order to reduce the degeneracy of the primers. These were used in a PCR reaction using first strand cDNA from leaf or tuber RNA or genomic DNA as template.
  • Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. One clone of each of the 5 PCR fragments was sequenced from either end and in one direction only, therefore the sequence cannot be guaranteed 100 % correct.
  • the exon sequences of the 1.8 and 1.6 kb bands (clones #43 & #34, designated pSJ134 and pSJ135 respectively) were found to be identical to pSJ98 (a pullulanase type DBE partial clone, described below) indicating that they are pullulanase type debranching enzymes.
  • the two clones pSJ134 and pSJ135 are not identical, sharing 96.3% identity over the entire sequence at the 5' end, and 89.8% identity over 160 nucleotides at the 3' end, after which the two sequences diverge.
  • Figure 2 A shows a comparison of the sequences of clones 134 and 135 at their 5' ends
  • Figure 2B shows a comparison of their sequences at the 3' end
  • Figures 3 A and 3B illustrate the presumed intron exon structure of the 5' and 3' ends (respectively) of clone 134
  • Figures 4A and 4B illustrate the presumed intron exon structure of the 5' and 3' ends respectively of clone 135.
  • two exons can be distinguished, separated by a 101 bp intron and the remainder of the exon sequences are present in the 3 ' end.
  • FIG. 1 shows a comparison of the 5' ends of these clones, whilst Figure 5B compares their 3' ends. As with the pullulanase clones, clones 133 and 137 were not identical (96 and 97% identity at the 5' and 3' ends respectively).
  • Figures 6A and 6B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 133.
  • Figures 7A and 7B illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 137. Only one intron can be distinguished at each end.
  • the 0.8 kb clone although it had the correct primers on both ends was not a debranching enzyme but had homology to a rice Expressed Sequence Tag (RICR2232A) which encodes a 70kDa endomembrane protein.
  • a new sense primer (PIAl) was designed to the isoamylase sequences just downstream of the DBE1 primer and this was use in a 3 'RACE PCR to clone the 3' end of the isoamylase gene.
  • Five ⁇ l of first strand cDNA and 25 pmol of each primer (PIAl and Ro) were used in a 50 ⁇ l PCR reaction (94°C 2 min followed by 30 cycles of 94°C 45 seconds, 55°C 25 seconds, 72°C 2 min).
  • One ⁇ l of this reaction was then used in a second PCR amplification using- PIAl and R, primers.
  • a major band of approx 1.5 kb (the expected size) was amplified from both leaf and mber cDNA templates.
  • the mber PCR fragment was purified on a 1% TAE agarose gel and then cloned in pT7Blue (clone designated pSJ132), The sequence and predicted ORF of this partial length clone is shown in Figure 8.
  • the ORF contains 429 aa and is 77.0% identical to the maize isoamylase protein encoded by the sugary- 1 gene (data not shown).
  • a plant transformation vector with the hygromycin selectable marker was constructed in which the 1.5 kb isoamylase cDNA from plasmid pSJ132 was inserted in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter. This vector (pSJ138) was then used to transform wild type and waxy potato plants.
  • GBSS granule bound starch synthase
  • a plant transformation vector (pSJ138) was constructed by inserting the 1.5 kb isoamylase cDNA from plasmid pSJ132 (as an Xba l-Sac I fragment) in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter into the plant transformation vector pSJ39 which had been cut with the same enzymes.
  • GBSS granule bound starch synthase
  • pSJ39 is a modified GPTV-HYG vector (Becker et al 1992) containing a 0.8 kb GBSS promoter and was constructed as follows: first the BamHI site between the hygromycin selectable marker and the gene 7 polyadenylation signal in pGPTV-HYG was destroyed by cutting and filling in with klenow polymerase to create pSJ35.
  • Hfndlll-EcoRI fragment of this vector (containing the GUS gene & nos polyadenylation signal) was replaced with the H dlll- EcoRI fragment (containing the GBSS promoter-GUS-nos poly(A) cassette) from plasmid pGB121 (obtained from R Visser, Wageningen) to create plasmid pSJ39.
  • Transformed potato plants cv Desiree were produced by co-cultivation of explants with Agrobacterium tumefaciens LBA 4404 containing plant transformation vector plasmids. Two explant types were used, microtubers and leaf fragments, both produced from stock cultures, requiring different methods in culture. Stocks of plantlets were maintained of wild type untransformed Desiree or selected lines previously transformed with antisense genes coding for enzymes of the starch biosynthetic pathway by regular transfer of single node explants using Murashige and Skoog media (1962 Physiol. Plant 15, 473) solidified with 0.8% agar with the sucrose concentration reduced from 3% to 1%.
  • Microtuber explants were produced by transferring nodes to the same medium with the sucrose concentration increased to 8% plus the addition of 2.5mg/l benzylaminopurine. All cultures were grown at 22°C with illumination from fluorescent tubes at 40 ⁇ E/sqm for 16 hours, except those cltures grown to produce microtubers, which were kept in darkness.
  • the protocol for microtuber explants, and that for leaf explants are detailed below.
  • Explants were initially precultured on the appropriate multiplication medium for two days before co-cultivation. Co-cultivation was for 10 minutes in an overnight culture of the Agrobacterium before explants were blotted on filter paper to remove excess bacteria. After blotting explants were transferred to filter paper on feeder layers and incubated in darkness at 22°C for two days.
  • the feeder layers consisted of a 9cm petri dish containing the appropriate multiplication media covered by 2ml of stationary phase tobacco suspension culture cells which were in turn covered by two layers filter paper.
  • Tissue culture and selection using microtuber explants was performed as follows. Microtubers were taken from stock when they were sufficiently large and mature to use. This occurred after 6-8 weeks from transfer of nodes to the high sucrose medium when they weighed more than 30mg and had started to turn from white to pink. Stocks were used for several months after mber initiation provided they remained dormant and no new shoots or stolons had emerged from the bud end. Each tuber was cut in half longitudinally through the terminal bud and the cut end put in contact with the medium.
  • the multiplication medium (Z5) used contained the salts and vitamins of Murashige and Skoog plus 3% sucrose, 0.2mg/l indole acetic acid, 5 mg/1 zeatin and 0.8% agar.
  • Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 15mg/l when HPTII was used.
  • the explants were transferred to fresh medium every two weeks. Explants had two transfers on medium Z5, followed by one transfer on the same medium, except indole acetic acid and zeatin were replaced by lOmg/1 of gibberellic acid (medium MSG). At each transfer all shoots were removed and discarded. The final transfer was to hormone- free Murashige and Skoog medium with the sucrose concentration reduced from 3% to 1%. Shoots were allowed to develop at this stage. Tissue culture and selection using leaf explants was performed as follows.
  • the multiplication medium used contained the salts and vitamins of Murashige and Skoog medium " plus 1.6% glucose, 0.02 mg/1 naphthyl acetic acid, 2mg/l zeatin * riboside and 0.8% agar. Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 5mg/l when HPTII was used. Cultures were transferred every two weeks to the same medium. After four transfers the cultures which were vitrified or showed poor shoot development were transferred to liquid Murashige and Skoog medium containing 1.6% sucrose only.
  • Transformation was confirmed as follows. Shoots which developed from either mber of leaf explants after the multiplication/organogenesis phase were transferred individually to hormone-free Murashige and Skoog medium containing 1% sucrose and 100 mg/1 kanamycin or 15mg/l hygromycin depending on the selection which was used. Only one shoot was taken from each explant unless the origin of separate shoots were well separated on the explant. Shoots which rooted on selection within two weeks were transferred to the same medium without selection and given an identifying number. When growth allowed sufficient tissue to be sampled, DNA was extracted from a few mgs of leaf and stem tissue of the culture using the method published by Edwards et al (1991 Nucleic Acids Research 19,(6) 1349) and transformation was confirmed by PCR using gene specific primers. Material was left in culture to allow individual shoots to be micropropagated. Positive shoots were micropropagated to be stored in vitro and also to provide planting material.
  • Representative samples of the mbers were stored for analysis and .possible regrowth and' 150-200g fresh weight was taken for starch extraction.
  • Washed mbers were diced and homogenised to a juice by passage through a Braun MP 75 centrifugal juicer.
  • the juice was diluted with tap water to a volume of approximately 3L in a 5L conical flask. After 30 minutes the unsedimented supernatant liquid was discarded and the remaining solids washed again with a further 3L of water. After a further 30 minutes the liquid was decanted and discarded.
  • the slurry of solids was poured through a 500 ⁇ m metal mesh filter which retained the bulk of the cell debris.
  • the crude starch which passed through the filter was washed in the same manner until no protein foam remained and only white starch settled on the base of the flask below a clear supernatant liquid.
  • the starch was harvested on filter paper using a Buchner funnel and washed on the funnel with two 500ml volumes of distiled water. Finally the starch was washed with 500ml of acetone and dried in a fume hood for approximately 30 minutes
  • the degree of branching of the starches was determined by ⁇ NMR spectroscopy (Gidley
  • Example 3 Cloning of a pullulanase type debranching enzyme from potato.
  • a PCR based cloning strategy was devised for isolating pullulanase type debranching enzymes from potato, using conserved domains within the known cloned gene sequences, of which spinach was the only plant gene (genbank SOPULSPO_l).
  • the amino acid sequence DGFRFDLMG was almost completely conserved (data not shown) and this is found at aa 546-554 of the spinach protein (964 aa in total). It was hoped therefore that this would also be present in the potato gene, as the sequence DGFRFD is also completely conserved in plant starch branching enzyme genes which belong to the same superfamily of amylolytic genes.
  • Peptide sequences from the purified potato debranching enzyme which were published in WO 95/04826 were also compared to the spinach sequence; of the 12 peptide sequences 10 made possible matches to the spinach sequence and of these peptide number 1 (RTLLVNLDSDDVKPEGGDNL. corresponding to aa 300-319 of the-spinach sequence,' identical residues underlined) was chosen to make a degenerate oligonucleotide sense primer (PDBEl ;20mer,64x) to be used in PCR with a degenerate antisense primer designed to the sequence DGFRFD (PDBE2; 18mer, 16x). These primers were used in a PCR reaction with mber or leaf first strand cDNA as template.
  • cDNA Five ⁇ l of cDNA was used as template in a 50 ⁇ l PCR reaction with 50 pmol of each degenerate primer (PDBEl & 2) under standard PCR conditions (28 cycles of 94°C 45 seconds, 48°C 25 seconds, 72°C 90 seconds).
  • the PCR products were separated on a 1% agarose gel in TAE buffer.
  • a strong band of the expected size (672bp) was amplified from the mber cDNA and a much weaker band from the leaf cDNA.
  • the mber amplified band was cut out and purified by binding to DEAE paper and then cloned in the pT7Blue vector (Novagen).
  • a diagram of the resulting vector is shown in Figure 11. In Figure 11, the symbols used have the same meanings as in Figure 9: pA-CaMV is the CaMV polyadenylation signal. This vector may then be used to transform potato plants, substantially as described in Example 2.
  • zymograms are usually used to determine the presence or absence of debranching enzymes. Protein extracts were separated on native 5% polyacrylamide gels containing 1% potato amylopectin. After separation the gel was incubated for 1-3 hours in 100 mM citrate buffer pH 5.5 containing 10 mM EDTA, 1 mM acarbose, and 2.5 mM DTT. The gel was then rinsed twice in deionized water and stained with iodine (Lugol's solution). Debranching enzymes stain as blue bands against a purple background, whereas amylases appear as clear bands.
  • the debranching enzyme bands in the amylopectin gel can thus be classified into isoamylase bands (which do not appear in the red pullulan containing gel) and pullulanase bands (which give clear bands in red pullulan containing gels).
  • RVA Rotary Visco Analyser
  • Viscosity development of starches was analysed using a Rapid Visco Analyser Series 4 instrument (Newport Scientific, Sydney, Australia). For the 13 minute profile, 2 g of starch was weighed into a sample cup and 25 ml of water was added to give a final starch concentration of 7.4 % (w/v) and the analysis was performed using the standard stirring and heating protocol according to the manufacturer's instructions. Viscosity was measured in centipoise (cP).
  • Figure 13 shows the viscosity profiles of tuber starches from plants transformed with the antisense isoamylase construct.
  • the linear plot shows the temperature profile.
  • a wild type control line 1302, unbroken thin line
  • Starch from line 1352 solid thick curve
  • Starch from line 1352 shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level
  • lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level (lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line).
  • the viscosity onset temperature is slightly increased for line
  • the latter PCR fragment (492 bp) was isolated using primers derived from the sequence of a genomic clone which hybridised to a degenerate oligonucleotide very similar to the PDBEl oligo which was used in the experiments described here.
  • the deduced amino acid sequence of the PCR fragment did not correspond exactly to the two peptide sequences from the purified protein (RTLLVNLDSDDVKPEGGDNL, SEQ. ID. NO. 30; and RLSSAGITHVHLLPTYNFA, SEQ. ID. NO. 31; differences are shown underlined).
  • the inventors have also cloned two PCR fragments (2.4 and 2.0 kb; pSJ133 and 137 respectively) from genomic DNA of potato which have significant homology to isoamylase genes. These clones differ in the size, and perhaps number, of introns and are about 96-97% identical ( Figure 4), suggesting that they are derived from different genes.
  • a cDNA fragment of approx 1500 bp was obtained by 3 'RACE; this cDNA encodes 429 aa which are 77% identical to the maize isoamylase gene and the inventors are confident that this gene is an isoamylase type DBE.
  • the two different isoamylase-type DBE genomic sequences isolated by the inventors relate to two different genes having slightly different functions or roles in the potato plant, and that similar multiple isoamylase-type genes exist in other plants. Different isoamylase-type genes might, for instance, be subjected- to different regulatory * controls. As the genomic sequences recovered are not full length genes, it is possible that the respective gene sequences may diverge in the uncloned portions.
  • pullulanase and isoamylase genes appear to be expressed in mbers and leaves since PCR bands of the correct size can be amplified from either mber or leaf first strand cDNA templates. The intensity of the amplified band is stronger in mbers for both DBE, possibly indicating that the expression level of both genes is higher in mbers, but this should be confirmed by northern analysis.

Abstract

Disclosed is a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase enzyme gene, together with constructs and host cells comprising the nucleic acid sequence, and methods of using the nucleic acid sequence.

Description

Title : Improvements in or Relating to Stability of Plant Starches
Field of the Invention
This invention relates to novel nucleotide sequences, nucleic acid constructs and host cells and organisms comprising said sequences, methods of altering plants using the sequences, and to products obtainable from the altered plants.
Background of the Invention
Starch, the major storage reserve in plants, consists of two main polysaccharides, amylose and amylopectin. Amylose is a linear polymer containing α-1,4 linked glucose units, while amylopectin is a highly branched polymer consisting of a α-1,4 linked glucan backbone with α-1,6 linked glucan branches. In most plant storage reserves, including tubers, amylopectin constitutes about 75% of the starch content. Until recently it was thought that amylopectin was synthesized by the concerted action of two enzymes: starch synthases, which elongate the glucan chains; and starch branching enzymes (SBE), which introduce branches to create amylopectin. It was further considered that it is the chain length specificity of the branching enzymes that determines the starch structure (Tolmasky & Krisman, 1987). Support for this hypothesis was provided by the characterisation of maize (Takeda et al 1993) and pea SBE (Burton et al 1995).
An alternative hypothesis which is gaining support, suggests that debranching enzymes play an important role in the synthesis of amylopectin and hence starch structure (Ball et al 1996; Nakamura,Y. 1996). The evidence for this comes mainly from an analysis of two mutants: sugary 1 mutants of maize synthesise a highly branched water soluble polysaccharide called phytoglycogen and have a defect in a debranching enzyme (Pan and Nelson 1984; James et al 1995) and a recently characterised mutant (STA7) of Chlamydomonas , which has a dramatic effect on starch synthesis, was shown to have a severe reduction in the activity of a debranching enzyme (Mouille et al 1996). It is desirable to be able to increase the degree of branching and/or reduce the chain length of the amylopectin in starches, especially waxy potato starches, in order to create more freeze/ thaw-stable starches. Very recently, it has been reported that overexpressing the E. coli glycogen branching enzyme in a waxy (i.e. amylose-free). potato does lead to a ' increase in the degree of branching of amylopectin (Kortsee et al 1996). However, the increase in branching was only 25 % , and the average chain length of the amylopectin was decreased only marginally - by 3 glucose units (from 25 to 22 glucose residues). An alternative approach to obtain a more highly-modified starch would be to decrease the expression of debranching enzymes in the potato tuber using an antisense or sense- suppression approach. To do this efficiently requires the cloning of a cDNA copy of a potato debranching enzyme.
Debranching enzymes (DBΕ) hydrolyse the αl-6-glucosidic linkages of α-glucan polymers and are classified into two types depending on their substrate specificities: (1) pullulanases (EC 3.2.1.41 , which are known in plants as "R- enzymes") which act on amylopectin and puUulan (a linear bacterial polymer consisting of 1-6 linked maltotriose units) but which cannot use glycogen as a substrate; and (2) isoamylases (EC 3.2.1.68) which act on amylopectin and glycogen but cannot use puUulan as a substrate.
Pullulanases have been purified from a number of plants including maize, rice, sorghum, oat, broad bean, potato, sugarbeet and spinach and the corresponding cDNA clones of maize, rice and spinach have been isolated (James et al 1995; Nakamura et al 1996; Renz et al 1995). In potato, both R-enzyme and isoamylase enzyme polypeptides have been characterised and purified (Drummond et al 1970; Ishizaki,Y et al 1983). A recent publication (WO 95/04826) detailed the purification and peptide sequence determination of a pullulanase type DBE. A cDNA encoding a potato DBE was described in a second patent application (WO 96/19581) which detailed the isolation of a partial length (492 bp) cDNA clone encoding a pullulanase type DBE, as well as the effect of downregulating the expression of this gene in transgenic antisense plants. An unspecified number of lines were generated and some showed a decrease in debranching enzyme activity (not quantitated) which also led to a slight modification in the swelling characteristics of the starch as measured by RVA (Rapid Viscoamylograph). These included a decrease in the maximum viscosity to about half of the control, and an increase in the setback viscosity (from 3300 cP in the control to 5200 in the most highly-modified plant line). No significant change in the amylose/amylopectin ratio was observed but there was an increase in the phosphate content of the starch (from 9 to 14.6 nmol G6P/mg starch). - '
The present application relates particularly to the isolation of nucleic acid sequences encoding potato debranching enzymes (especially isoamylase type debranching enzymes) and to the uses thereof.
Summary of the Invention
In a first aspect the invention provides a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene. Those skilled in the art will appreciate that the nucleic acid sequence will comprise at least one region which is characteristic of isoamylase-type debranching enzymes and which is not present in pullulanase type debranching enzymes. The nucleic acid sequence will preferably be at least 200bp long, more preferably at least 300-600bp long. Conveniently the sequence is one which is derived or obtained from potato plants.
The nucleic acid sequence of the invention may be, for instance, a genomic sequence, or may be a cDNA sequence. The nucleic acid sequence of the invention may comprise non- coding portions (which are transcribed, but not translated), and/or may comprise coding portions, which are translated into amino acid residues in the full length native gene. As described below, either translated or non-translated portions may be useful in certain techniques, and both therefore possess utility.
In a particular embodiment, the nucleic acid sequence comprises nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8, or a functional equivalent thereof. (This sequence includes a portion encoding the amino acid sequence MDWF/YNH, which portion is typically present in the nucleic acid sequences of the invention). Functionally equivalent nucleic acid sequences include sequences which encode substantially the same polypeptide, but which differ in nucleotide sequence from mat shown in Figure 8 by virtue of the degeneracy of the genetic code. For example, a nucleic acid sequence may be altered (e.g. "codon optimised") for expression in a particular host cell or host organism, such that the nucleotide sequence differs substantially whilst the amino acid sequence of the encoded polypeptide is unchanged. Typically, functionally equivalent nucleic acid sequences are those- which will hybridise under stringent hybridisation -conditions (e.g..as- described by Sambrook et al, Molecular Cloning. A Laboratory Manual, CSH, i.e. washing with O. lxSSC, 0.5% SDS at 68°C) with the sequence shown in Figure 8. Figures_6A-7B illustrate some related sequences, which are also in accordance with the present invention. These are genomic sequences with large stretches of intron sequence, which introns are not represented in rnRNA. The sequences illustrated in Figures 6A-7B thus comprise both coding and non-coding portions.
DNA sequences functionally equivalent to that shown in Figure 8 will preferably comprise at least 200, more preferably 300-600bp, and typically will exhibit at least 85% identity (preferably at least 90%, and more preferably at least 95% identity) with the corresponding region of the DNA sequence shown in Figure 8. Those skilled in the an will readily be able to conduct a sequence alignment between the putative functionally equivalent sequence and that detailed in Figure 8 - the identity of the two sequences is to be compared in those regions which are aligned by standard computer software, which aligns corresponding regions of the sequences.
In a second aspect the invention provides a replicable nucleic acid construct comprising the nucleic acid sequence of the first aspect defined above. The construct may typically comprise a selectable marker (e.g. kanamycin or hygromycin-resistance) and may allow for transcription (and possibly translation) of the nucleic acid sequence of the invention. Conveniently therefore the construct will comprise a promoter (especially a promoter sequence operable in a plant and/or a promoter operable in a bacterial cell), and one or more regulatory signals (such as polyadenylation signals) known to those skilled in the art.
The nucleic acid sequence of the invention can be introduced into plants which express a homologous sequence encoding an isoamylase enzyme, in such a way that the introduced sequence interferes with the expression of the homologous sequence. Thus, for example, the nucleic acid sequence of the invention may be operably linked in the antisense orientation to a suitable promoter active in the plant into which the sequence is to be introduced, so as to reduce the levels of expression of the homologous isoamylase enzyme present in the plant-. _ -
Additionally, it has recently been demonstrated in other experimental systems that "sense suppression" can also occur (i.e. expression of an introduced sequence operably linked in the sense orientation can interfere, by some unknown mechanism, with the expression of the homologous, native gene), as described by Matzke & Matzke (1995 Plant Physiol. 107, 679-685). Any one of the methods mentioned by Matzke & Matzke could, in theory, be used to affect the expression in a host of a homologous isoamylase gene.
It has been found in some experimental systems that there is no requirement for translation of the introduced sequence in order for an inhibitory effect to be observed, and it is believed that antisense methods are mainly operable by the production of antisense mRNA which hybridises to the sense mRNA, preventing its translation into functional polypeptide, possibly by causing the hybrid RNA to be degraded (e.g. Sheehy et al, 1988 PNAS 55, 8805-8809; Van der Krol et al, Mol. Gen. Genet. 220, 204-212). Sense suppression also requires homology between the introduced sequence and the target gene, but the exact mechanism is unclear. It is apparent that, in relation to both antisense and sense suppression, neither a full length nucleotide sequence, nor a "native" sequence (i.e. the introduced sequence need not be 100% identical to the sequence of the homologous native gene) is essential. Preferably the nucleic acid used will comprise at least 300-600bp of sequence, but by simple trial and error other fragments (smaller or larger) may be found which are functional in altering the characteristics of the plant.
Accordingly, in a third aspect the invention provides a method of altering a plant by inhibiting the expression of an isoamylase gene therein, the method comprising introducing into the plant the nucleic acid sequence of the invention, operably linked (in the sense or anti-sense orientation) to a promoter active in the plant, wherein the isoamylase gene in the plant has homology to the introduced sequence. The introduced nucleic acid will typically comprise at least 200bp, more preferably 300-600bp of sequence having at least 80% (advantageously at least 85%, desirably over 90%) sequence identity with the native isoamylase gene(s) present in the plant.
Advantageously the "plant will be a plant which normally comprises large amounts oi J starch, such as potato, sweet potato, maize, wheat, barley, oat, cassava, pea, rice and the like. It is probable that the greater the homology between the introduced sequence and the native gene, the greater the inhibition of expression of the native gene. Preferably the plant is therefore a potato plant, and/or a plant which has a reduced amylose content (e.g. the "waxy" mutation of potato or the "LAM" [low amylose mutant] strain of pea).
Inhibition of the isoamylase gene might be expected to affect the properties of the starch present in the plant. In particular it might be expected to result in a starch having increased branching and/or shorter chain length. The obtaining of starch having such properties is a particular object of the present invention.
It may also be advantageous to introduce into the plant one or more additional nucleic acid sequences, especially sequences which might also be expected to have an effect on synthesis and/or metabolism of starch in the plant. Particularly preferred are sequences which inhibit the expression of a pullulanase debranching enzyme in the plant. Plant pullulanase sequences are known to those skilled in the art (e.g. WO 96/19581), and a portion of a potato pullulanase cDNA sequence is also disclosed herein. The additional nucleic acid sequence will typically be homologous to a portion of a native gene in the plant and, as described above, may be introduced into the plant operably linked to a suitable promoter in either the sense or the anti-sense orientation.
The introduced sequence of the invention and the one or more additional sequences may be operably linked to a single promoter (which would ensure both sequences were transcribed at essentially the same time), or may be operably linked to separate promoters (which may be necessary for optimal expression). Where separate promoters are employed they may be identical to each other or different. Suitable promoters are well known to those skilled in the art and include both constitutive and inducible types. Examples include the CaMV 35S promoter (e.g. single or tandem repeat) and the GBSS type I or patatin promoters of potato. Advantageously the promoter will be tissue-specific. Desirably the promoter will cause expression of the operably linked sequence at substantial levels only in the tissue of the plant where starch synthesis and/or starch storage mainly occurs. Thus, for "example, where the sequence is introduced into a potato plant, the* operably linked promoter may be tuber-specific, such as the patatin promoter.
Those skilled in the art will also appreciate that, if additional nucleic acid sequences are to be introduced into the plant, they may be present on the same nucleic acid plant transformation vector as the portion of isoamylase-encoding sequence, or may be introduced on separate vectors (for example by re-transformation). The sequence of the invention, and the one or more additional sequences if desired, can be introduced into the plant by any one of a number of well-known techniques (e.g. Agrobacterium-mediated transformation, or by "biolistic" methods).
In another aspect, the invention provides a plant cell, or a plant or the progeny thereof, which has been altered by the method defined above. Altered plant cells, into which the sequence of the invention has been introduced, may be grown into plantlets by conventional methods well-known to those skilled in the an. The progeny of an altered plant may be obtained, for example, by vegetative propagation, or by crossing the altered plant and reserving the seed so obtained. The invention also provides pans of the altered plant, such as storage organs. Conveniently, for example, the invention provides tubers comprising altered starch, said tubers being obtained from an altered plant or the progeny thereof.
The invention also provides a method of obtaining starch from an altered plant, the plant being obtained by the method defined above. Starch may be extracted from the plant by any of the known techniques (e.g. milling). The invention further provides starch obtainable from a plant altered by the method defined above, the starch having altered propenies compared to starch extracted from an equivalent but unaltered plant. Conveniently the altered starch is obtained from an altered plant selected from the group consisting of cassava, potato, pea, tomato, maize, wheat, barley, oat, sweet potato and rice. Typically the altered starch will have an increased degree of branching and/or reduced amylopectin chain length, compared to starch extracted from an equivalent but unaltered plant. In general, such altered starch obtained by means of the present invention is found to possess different viscosity charcteristics compared to starch extracted from equivalent, but unaltered, plants. In particular, the inventors have found that starch obtained from plants altered by the method of the invention may have reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument, (available from Newport Scientific, Sydney, Australia) according to the manufacturer's standard stirring and heating protocol. Alternatively, or additionally, the altered starch may have higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, (as determined, for example, by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument). Further, the altered starch may have an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, (as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument).
The terms "peak viscosity", "setback viscosity" and "viscosity onset temperature" are well known and understood by the person skilled in the art. By way of explanation for the novice reader, the viscosity of starch preparations is generally investigated by heating an aqueous sample of the starch under controlled conditions of temperature increase, temperature maintenance, and subsequent temperature decrease and with controlled stirring, using an instrument known as a Visco analyser, which produces a viscosity profile called a "viscoamylograph". The "peak viscosity" is the maximum viscosity which is attained during the temperature increase phase. The "setback viscosity" is the viscosity obtained at the end of the viscoamylograph. The viscosity onset temperature is the temperature at which a sudden increase of viscosity is apparent on the viscoamylograph.
For the purposes of the present invention, an "equivalent, but unaltered" plant may be considered as a plant which has a substantially identical genotype to a plant altered by the method of the invention, except for the introduced sequences present in the altered plant of the invention. Also to be considered as an equivalent but unaltered plant are those plants which comprise the introduced sequence but wherein the introduced sequence has not affected the starch properties of the plant.
In a further aspect, the invention provides a nucleic acid sequence encoding at least a portion of a potato pullulanase type debranching enzyme, the sequence comprising- substantially nucleotides 46-774 of the nucleic acid sequence shown in Figure 10, or a functional equivalent thereof. The term "functional equivalent" should be interpreted as explained previously, but with reference (in this aspect of the invention) to Figure 10 rather than Figure 8.
Similarly, the invention provides nucleic acid constructs, and altered host plant cells and organisms, comprising the pullulanase-type DBE nucleic acid sequence defined immediately above.
The invention will now be further described by way of illustrative example and with reference to the accompanying drawings, in which:
Figure 1 shows a comparison of the known amino acid sequences of various putative isoamylase proteins. The shaded area indicates residues (single letter amino acid code) that are identical to the maize protein. Dashes indicate gaps introduced to maximise the alignment. Although the whole sequences were compared, only the most conserved region is shown. Sequences are identified at the right; A10906_l is an artificial sequence, A37035 is from a Pseudomonas species SMP1, HIU32761 is from Haemophilus influenzae, ISOA_PSESP is from Pseudomonas amylodermosa and ZMU18908_1 is from Zea mays (corn);
Figures 2A and 2B show a comparison of the 5' and 3' ends (respectively) of two partial pullulanase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
Figures 3A and 3B show the DNA sequence (SEQ. ID. NO.s 1 and 4 respectively) and predicted intron exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 2 and 3) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
Figures 4A and 4B-show the DNA sequence (SEQ. ID. NO.s 5 and 8 respectively) and- predicted intron/exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 6 and 7) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
Figures 5 A and 5B show a comparison of the 5' and 3' ends (respectively) of two partial isoamylase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
Figures 6 A and 6B show the DNA sequence (SEQ. ID. NO.s 9 and 11 respectively) and predicted intron/exon strucmre, including predicted amino acid sequence (SEQ. ID. NO. 10) at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
Figures 7A and 7B show the DNA sequence (SEQ. ID. NO.s 12 and 13 respectively) and predicted intron/exon strucmre at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
Figure 8 shows the DNA sequence (SEQ. ID. NO. 14), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 15) of a partial length potato debranching enzyme (isoamylase) cDNA clone (pSJ132, described below); nucleotides 79-1595, including the poly(A) tail, are isoamylase, the other sequence is derived from pT7Blue vector;
Figure 9 is a schematic representation of the plant transformation vector pSJ138;
Figure 10 shows the DNA sequence (SEQ. ID. NO. 16), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 17) of a pullulanase type partial length potato debranching enzyme cDNA clone (pSJ98, described below); nucleotides 46-774 are DBE, the other sequence is derived from pT7Blue vector;
Figure 11 is a schematic representation of a "double" plant transformation vector, comprising partial isoamylase- and pullulanase-type debranching enzyme sequences operably linked in the anti-sense orientation to separate GBSS promoters;
Figure 12 shows a zymogram (using a 5% polyacrylamide gel containing 1 % amylopectin) of mber extracts from potato lines transformed with an antisense isoamylase construct in accordance with the invention; and
Figure 13 shows viscosity (RVA) profiles of starch from potato lines transformed with an antisense isoamylase construct, and from a wild type control (1302).
EXAMPLES
Example 1 : Isolation of a partial cDNA clone of a potato isoamylase.
Throughout the examples described in the present specification, standard procedures were performed essentially according to Sambrook et al (1989). DNA sequencing was performed on an ABI automated DNA sequencer and sequences manipulated using DNASTAR software for the Macintosh computer.
Oligonucleotides
The following oligonucleotides (SEQ ID. NO.s 18-29 respectively) were employed in the examples described below:
RoRidT!7 AAG GAT CCG TCG AC A TCG ATA ATA CGA CTC ACT ATA GGGA(T17)
Ro AAG GAT CCG TCG ACA TC
Ri GAC ATC GAT AAT ACG AC
PDBE1 GAC/T GAC/T GTn AAA G CCT GAA/G GG
PDBE2 ATC AAA TCT/G A/GAA nCC ATC DBE1 ATG GAT GTT GT(T/C/A) TA/TC/T AAT/C CAT
DBE2 TCA AAA/T CG/TA/G AAi CCA TC
PIA1 GAG GCA TTG AC A AC A GTG TG
"PIA2 CGT GAC ATG GTA CGG CAG TT
PIA3 AAC TGC CGT ACC ATG TCA CG
PIA4 GGT TAT AGA TGG CAG CCG TT
PIA5 AAC GGC TGC CAT CTA TAA CC
Potato DNA isolation
Genomic DNA was isolated from potato leaves using a modified CTAB (cetyltrimethyl ammonium bromide) method (Murray and Thompson, 1980). Leaf tissue (4 gm) was frozen in liquid nitrogen and ground in a mortar and pestle and transferred to a 50 ml polypropylene centrifuge tube (Falcon) to which was added 40 ml of extraction buffer ( 2% w/v CTAB, 100 mM Tris-HCl pH 8.0, 1.4 M NaCl, 10 mM 3-mercaptoefhanol and 20 mM EDTA) and incubated at 65°C for 30 min. After cooling, the mixture was split into two tubes and 15 ml of chloroform was added to each followed by gentle (end over end) mixing for 15 min at room temperature. The tubes were then centrifuged for 5 min at 5000g and the pooled aqueous phases were re-extracted with 5 ml of chloroform. The DNA was then precipitated by incubating on ice for 30 minutes with an equal volume of isopropanol and centrifuged for 5 minutes at 3000g. The pellet was washed once with 70% ethanol, briefly air-dried and resuspended in TE pH 8.0 containing 20 μg ml RNase A. After incubation at room temperamre for 30 minutes the DNA was extracted with 5ml of chloroform, one tenth volume of 3 M sodium acetate (NaAc) pH 5.2 was added and the DNA precipitated with two volumes of ethanol. After centrifugation and washing as above, the DNA was resuspended in 2 ml of TE buffer at pH 8.0 and estimated to be approximately 150 ng/μl by fluorometric measurement.
RNA isolation and cDNA synthesis
RNA was isolated from potato plants by the method of Logemann et al (1987). Tuber material consisted of small tubers (<1 gm ) harvested from a mature plant. Leaf material was from source leaves (>10 cm) of a healthy vigorously growing plant from the greenhouse. Five microgram of RNA was heated in water for 3 minutes at 65°C and then reverse transcribed in a 50 μl reaction using 10 pmol of RoRidT17 as primer and MMLV reverse transcriptase (Stratascript 50 units; reaction conditions 50mM Tris-HCl (pH 8. 3), 75mM KC1, lOmM DTT, 3mM MgCl2, 0.5mM each dNTP, lU/μl RNasin and incubation for 1 hour at 37°C); The reaction was then diluted to 200 μl with TE-pH 8.0 and stored^ at 4°C.
Isoamylase cloning
No amino acid sequence information for isoamylase enzymes from potato was publicly available at the time this work was performed, therefore the cloning strategy relied only on conserved sequence regions among known or putative isoamylase type debranching enzymes from other sources. As shown in Figure 1, there are two regions within isoamylase proteins that are conserved. One of these is the same DGFRFD sequence found in the pullulanase enzymes (see example 3) and the second (MDWFΥNH) is found approx 70 aa from this sequence towards the N-terminus. Degenerate oligonucleotide primers were made corresponding to these sequences (DBE2 & DBE1 respectively, see above), taking into consideration the codon usage in plant genes in order to reduce the degeneracy of the primers. These were used in a PCR reaction using first strand cDNA from leaf or tuber RNA or genomic DNA as template.
Approximately 50ng of potato genomic DNA or 5μl of first strand cDNA were used as template in a 50μl PCR reaction containing 25pmol of each degenerate primer (DBE1 & 2) under standard PCR conditions (30 cycles of 94°C 60 seconds, 50°C 60 seconds, 72°C 60 seconds). The PCR products were separated on a 1% agarose gel in TAE buffer. The expected size fragment (240 bp) was amplified from both leaf and tuber cDNA templates although the signal was stronger in the latter. However when genomic DNA was used as template, 5 strong bands of approx 2.4, 2.0, 1.8, 1.6 and 0.6 kb were amplified indicating that intron(s) are present within this portion of the genes. This pattern was very reproducible and only occurred when both primers were used in the PCR reaction. These 5 bands were cut out and purified using Qiaquick columns (Qiagen) and then cloned in the pT7Blue vector (Novagen).
Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. One clone of each of the 5 PCR fragments was sequenced from either end and in one direction only, therefore the sequence cannot be guaranteed 100 % correct.
The exon sequences of the 1.8 and 1.6 kb bands (clones #43 & #34, designated pSJ134 and pSJ135 respectively) were found to be identical to pSJ98 (a pullulanase type DBE partial clone, described below) indicating that they are pullulanase type debranching enzymes. The two clones pSJ134 and pSJ135 are not identical, sharing 96.3% identity over the entire sequence at the 5' end, and 89.8% identity over 160 nucleotides at the 3' end, after which the two sequences diverge. Figure 2 A shows a comparison of the sequences of clones 134 and 135 at their 5' ends, whilst Figure 2B shows a comparison of their sequences at the 3' end. Figures 3 A and 3B illustrate the presumed intron exon structure of the 5' and 3' ends (respectively) of clone 134. Similarly, Figures 4A and 4B illustrate the presumed intron exon structure of the 5' and 3' ends respectively of clone 135. In both clones, at the 5' end two exons can be distinguished, separated by a 101 bp intron and the remainder of the exon sequences are present in the 3 ' end.
The 2.4 and 2.0 kb bands (clones #44 & #42, designated pSJ133 and pSJ137 respectively) showed most homology to the isoamylase genes (data not shown). Figure 5 A shows a comparison of the 5' ends of these clones, whilst Figure 5B compares their 3' ends. As with the pullulanase clones, clones 133 and 137 were not identical (96 and 97% identity at the 5' and 3' ends respectively). Figures 6A and 6B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 133. Similarly, Figures 7A and 7B illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 137. Only one intron can be distinguished at each end.
The 0.8 kb clone, although it had the correct primers on both ends was not a debranching enzyme but had homology to a rice Expressed Sequence Tag (RICR2232A) which encodes a 70kDa endomembrane protein.
A new sense primer (PIAl) was designed to the isoamylase sequences just downstream of the DBE1 primer and this was use in a 3 'RACE PCR to clone the 3' end of the isoamylase gene. Five μl of first strand cDNA and 25 pmol of each primer (PIAl and Ro) were used in a 50 μl PCR reaction (94°C 2 min followed by 30 cycles of 94°C 45 seconds, 55°C 25 seconds, 72°C 2 min). One μl of this reaction was then used in a second PCR amplification using- PIAl and R, primers. A major band of approx 1.5 kb (the expected size) was amplified from both leaf and mber cDNA templates. The mber PCR fragment was purified on a 1% TAE agarose gel and then cloned in pT7Blue (clone designated pSJ132), The sequence and predicted ORF of this partial length clone is shown in Figure 8. The ORF contains 429 aa and is 77.0% identical to the maize isoamylase protein encoded by the sugary- 1 gene (data not shown).
Example 2: Transformation of plants with antisense isoamylase
A plant transformation vector with the hygromycin selectable marker was constructed in which the 1.5 kb isoamylase cDNA from plasmid pSJ132 was inserted in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter. This vector (pSJ138) was then used to transform wild type and waxy potato plants.
Construction of plant transformation vector
A plant transformation vector (pSJ138) was constructed by inserting the 1.5 kb isoamylase cDNA from plasmid pSJ132 (as an Xba l-Sac I fragment) in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter into the plant transformation vector pSJ39 which had been cut with the same enzymes. pSJ39 is a modified GPTV-HYG vector (Becker et al 1992) containing a 0.8 kb GBSS promoter and was constructed as follows: first the BamHI site between the hygromycin selectable marker and the gene 7 polyadenylation signal in pGPTV-HYG was destroyed by cutting and filling in with klenow polymerase to create pSJ35. The Hfndlll-EcoRI fragment of this vector (containing the GUS gene & nos polyadenylation signal) was replaced with the H dlll- EcoRI fragment (containing the GBSS promoter-GUS-nos poly(A) cassette) from plasmid pGB121 (obtained from R Visser, Wageningen) to create plasmid pSJ39. Plasmid pGB121 was constructed by inserting the 0.8 kb GBSS promoter from genomic clone LGBSSwt-6 (Visser et al 1989) as an Hinάlll-Nsil (klenow filled in) fragment into the Ht/zdIII-ΛtI(T4 DNA polymerase blunted) sites of plasmid pBI121 (Jefferson et al 1987). Construction of pSJ138 is illustrated schematically in Figure 9. In Figure 9 the black line represents the DNA sequence. The hashed line represents the bacterial plasmid backbone (containing the origin of replication and bacterial selection marker) and is not shown in full. The filled triangles represent the T-DNA borders (RB = right border and LB = left border). Relevant restriction enzyme sites are shown above- the black line with the approximate distances (in kilobases kb) between sites marked by an asterisk shown underneath. The thinnest arrows represent polyadenylation signals (pA-nos = nopaline synthase, pAg7 = Agrobacterium gene 7), the intermediate arrows denote protein coding regions (HYG = hyromcin resistance gene etc) and the thick arrows indicate promoter regions (P-GBSS = granule bound starch synthase and P-nos = nopaline synthase).
Potato transformation protocol
Transformed potato plants cv Desiree were produced by co-cultivation of explants with Agrobacterium tumefaciens LBA 4404 containing plant transformation vector plasmids. Two explant types were used, microtubers and leaf fragments, both produced from stock cultures, requiring different methods in culture. Stocks of plantlets were maintained of wild type untransformed Desiree or selected lines previously transformed with antisense genes coding for enzymes of the starch biosynthetic pathway by regular transfer of single node explants using Murashige and Skoog media (1962 Physiol. Plant 15, 473) solidified with 0.8% agar with the sucrose concentration reduced from 3% to 1%. Microtuber explants were produced by transferring nodes to the same medium with the sucrose concentration increased to 8% plus the addition of 2.5mg/l benzylaminopurine. All cultures were grown at 22°C with illumination from fluorescent tubes at 40μE/sqm for 16 hours, except those cltures grown to produce microtubers, which were kept in darkness. The protocol for microtuber explants, and that for leaf explants (based ona modification of that published by Rocha-Sosa et al 1989, EMBO J. 8, 23), are detailed below.
Explants were initially precultured on the appropriate multiplication medium for two days before co-cultivation. Co-cultivation was for 10 minutes in an overnight culture of the Agrobacterium before explants were blotted on filter paper to remove excess bacteria. After blotting explants were transferred to filter paper on feeder layers and incubated in darkness at 22°C for two days. The feeder layers consisted of a 9cm petri dish containing the appropriate multiplication media covered by 2ml of stationary phase tobacco suspension culture cells which were in turn covered by two layers filter paper.
After two days the explants were removed and washed in Murashige and Skoog medium' (without sucrose or agar) containing 500μg/ml cefataxime, blotted on filter paper and transferred to multiplication medium containing 500μg/ml cefataxime. After a further five days the explants were further transferred to the same medium containing the selection agent. Selection was effected by the use of the NPTII gene in the construct and addition of kanamycin in the tissue culture process or the HPTII gene with additions of hygromycin. To achieve double transformations lines resistant to kanamycin containing the NPTII gene and a gene to modulate starch biosynthesis were subsequently transformed with a construct containing the HPTII using hygromycin selection. This was reversed if the line used had been originally transformed with a HPTII containing construct and NPTII and kanamycin were used for selection.
Tissue culture and selection using microtuber explants was performed as follows. Microtubers were taken from stock when they were sufficiently large and mature to use. This occurred after 6-8 weeks from transfer of nodes to the high sucrose medium when they weighed more than 30mg and had started to turn from white to pink. Stocks were used for several months after mber initiation provided they remained dormant and no new shoots or stolons had emerged from the bud end. Each tuber was cut in half longitudinally through the terminal bud and the cut end put in contact with the medium. The multiplication medium (Z5) used contained the salts and vitamins of Murashige and Skoog plus 3% sucrose, 0.2mg/l indole acetic acid, 5 mg/1 zeatin and 0.8% agar. Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 15mg/l when HPTII was used. The explants were transferred to fresh medium every two weeks. Explants had two transfers on medium Z5, followed by one transfer on the same medium, except indole acetic acid and zeatin were replaced by lOmg/1 of gibberellic acid (medium MSG). At each transfer all shoots were removed and discarded. The final transfer was to hormone- free Murashige and Skoog medium with the sucrose concentration reduced from 3% to 1%. Shoots were allowed to develop at this stage. Tissue culture and selection using leaf explants was performed as follows. Expanded leaves were taken from stock cultures and cut into fragments comprising a half or a third of the leaf. The multiplication medium used contained the salts and vitamins of Murashige and Skoog medium" plus 1.6% glucose, 0.02 mg/1 naphthyl acetic acid, 2mg/l zeatin* riboside and 0.8% agar. Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 5mg/l when HPTII was used. Cultures were transferred every two weeks to the same medium. After four transfers the cultures which were vitrified or showed poor shoot development were transferred to liquid Murashige and Skoog medium containing 1.6% sucrose only.
Transformation was confirmed as follows. Shoots which developed from either mber of leaf explants after the multiplication/organogenesis phase were transferred individually to hormone-free Murashige and Skoog medium containing 1% sucrose and 100 mg/1 kanamycin or 15mg/l hygromycin depending on the selection which was used. Only one shoot was taken from each explant unless the origin of separate shoots were well separated on the explant. Shoots which rooted on selection within two weeks were transferred to the same medium without selection and given an identifying number. When growth allowed sufficient tissue to be sampled, DNA was extracted from a few mgs of leaf and stem tissue of the culture using the method published by Edwards et al (1991 Nucleic Acids Research 19,(6) 1349) and transformation was confirmed by PCR using gene specific primers. Material was left in culture to allow individual shoots to be micropropagated. Positive shoots were micropropagated to be stored in vitro and also to provide planting material.
Growth of Transformed Lines
Five plants from each line, when 50- 100mm high, were transferred to compost made up of 50% horticultural sand and 50% Levington F2 peat-based compost in 20mm square modular pots and maintained at 20°C (day) and 15°C (night) in a growth room illuminated for 16 hours with high pressure sodium lamps at an illumination of 400 μE/sq m. After watering they were covered within a small propagator and shaded from illumination. After 7-10 days when new growth was apparent the shading was removed and the plants grown on, with an intermediate potting to 70mm diameter pots. Finally the five plants were grown to maturity together in a 250mm diameter pot in Levington F2 compost under glass. Sixteen to eighteen weeks after transfer from culture when the foliage began to die down all the mbers were harvested.
Representative samples of the mbers were stored for analysis and .possible regrowth and' 150-200g fresh weight was taken for starch extraction.
Starch extraction
Washed mbers were diced and homogenised to a juice by passage through a Braun MP 75 centrifugal juicer. The juice was diluted with tap water to a volume of approximately 3L in a 5L conical flask. After 30 minutes the unsedimented supernatant liquid was discarded and the remaining solids washed again with a further 3L of water. After a further 30 minutes the liquid was decanted and discarded. The slurry of solids was poured through a 500μm metal mesh filter which retained the bulk of the cell debris. The crude starch which passed through the filter was washed in the same manner until no protein foam remained and only white starch settled on the base of the flask below a clear supernatant liquid. The starch was harvested on filter paper using a Buchner funnel and washed on the funnel with two 500ml volumes of distiled water. Finally the starch was washed with 500ml of acetone and dried in a fume hood for approximately 30 minutes.
Starch analysis
The degree of branching of the starches was determined by Η NMR spectroscopy (Gidley
1985), and more detailed analysis performed as dscribed in example 5 below.
Example 3: Cloning of a pullulanase type debranching enzyme from potato.
A PCR based cloning strategy was devised for isolating pullulanase type debranching enzymes from potato, using conserved domains within the known cloned gene sequences, of which spinach was the only plant gene (genbank SOPULSPO_l). The amino acid sequence DGFRFDLMG was almost completely conserved (data not shown) and this is found at aa 546-554 of the spinach protein (964 aa in total). It was hoped therefore that this would also be present in the potato gene, as the sequence DGFRFD is also completely conserved in plant starch branching enzyme genes which belong to the same superfamily of amylolytic genes. Peptide sequences from the purified potato debranching enzyme which were published in WO 95/04826 were also compared to the spinach sequence; of the 12 peptide sequences 10 made possible matches to the spinach sequence and of these peptide number 1 (RTLLVNLDSDDVKPEGGDNL. corresponding to aa 300-319 of the-spinach sequence,' identical residues underlined) was chosen to make a degenerate oligonucleotide sense primer (PDBEl ;20mer,64x) to be used in PCR with a degenerate antisense primer designed to the sequence DGFRFD (PDBE2; 18mer, 16x). These primers were used in a PCR reaction with mber or leaf first strand cDNA as template.
Five μl of cDNA was used as template in a 50 μl PCR reaction with 50 pmol of each degenerate primer (PDBEl & 2) under standard PCR conditions (28 cycles of 94°C 45 seconds, 48°C 25 seconds, 72°C 90 seconds). The PCR products were separated on a 1% agarose gel in TAE buffer. A strong band of the expected size (672bp) was amplified from the mber cDNA and a much weaker band from the leaf cDNA. The mber amplified band was cut out and purified by binding to DEAE paper and then cloned in the pT7Blue vector (Novagen). Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. The resulting plasmid was designated pSJ98 and the sequence is shown in Figure 10. Comparison of this sequence to the spinach gene showed it to be 75.7% identical at the DNA level and 75.5 % at the protein (data not shown). It is concluded therefore that this gene belongs to the pullulanase class of debranching enzymes. In all, three clones of the potato DBE PCR in pT7Blue were sequenced (#4, 5 & 6) #4 = pSJ98, #5 = pSJ136 opposite orientation (17305-506). Clone #6 was found to have a 34bp deletion approx 100 bp from the 5' end, which caused a shift in the reading frame resulting in a truncated polypeptide.
Example 4 Construction of double antisense isoamylase and pullulanase plant transformation vector
A cassette consisting of the 0.7 kb pullulanase type DBE cDNA from pSJ98 in an antisense orientation between the GBSS promoter and CaMV poly A signal (Guerineau et al 1988), was inserted as a blunt fragment into the unique Pme I site of the plant transformation vector pSJ138. A diagram of the resulting vector is shown in Figure 11. In Figure 11, the symbols used have the same meanings as in Figure 9: pA-CaMV is the CaMV polyadenylation signal. This vector may then be used to transform potato plants, substantially as described in Example 2.
Example 5 Analysis of potato plants transformed with Isoamylase antisense construct (from example 2)
Zymograms
There is no specific assay for debranching enzymes. Therefore zymograms are usually used to determine the presence or absence of debranching enzymes. Protein extracts were separated on native 5% polyacrylamide gels containing 1% potato amylopectin. After separation the gel was incubated for 1-3 hours in 100 mM citrate buffer pH 5.5 containing 10 mM EDTA, 1 mM acarbose, and 2.5 mM DTT. The gel was then rinsed twice in deionized water and stained with iodine (Lugol's solution). Debranching enzymes stain as blue bands against a purple background, whereas amylases appear as clear bands.
In order to distinguish between the two classes of debranching enzymes, isoamylases and pullulanases, a second set of protein extracts was separated on another polyacrylamide gel containing 1% amylopectin. After the run the proteins were transferred onto a 10% polyacrylamide gel containing 1% red pullulan (Megazyme, Wicklow, Ireland) using standard Western blotting apparatus. The red pullulan containing gel was then incubated as described above for the amylopectin containing gel. Pullulanase bands appear as clear bands against the red background. The debranching enzyme bands in the amylopectin gel can thus be classified into isoamylase bands (which do not appear in the red pullulan containing gel) and pullulanase bands (which give clear bands in red pullulan containing gels).
In Figure 12 mber extracts of ten different antisense lines were analysed in a zymogram as described above. The upper band with a low electrophoretic mobility is a debranching enzyme as it stains blue in the amylopectin containing gel against a purple background. By comparison with the band pattern of a red pullulan containing gel (data not shown) it could be demonstrated that this band is not a pullulanase and can therefore be classified as an isoamylase. Transformed potato line 1352 clearly lacks this isoamylase band. In this line isoamylase expression was successfully inhibited by the antisense construct. The lower band apparent in Figure 12 is an amylase which stains as a clear zone in a purple background. Depending on incubation time, two additional debranching enzyme bands could be detected which are of the pullulanase type and not affected in line 1352.
Analysis of starch by RVA (Rapid Visco Analyser)
In addition to the examination of isoamylase enzyme expression by zymograms, the physical properties of mber starch was analysed, in order to test whether the lack of the isoamylase enzyme alters the starch properties.
Viscosity development of starches was analysed using a Rapid Visco Analyser Series 4 instrument (Newport Scientific, Sydney, Australia). For the 13 minute profile, 2 g of starch was weighed into a sample cup and 25 ml of water was added to give a final starch concentration of 7.4 % (w/v) and the analysis was performed using the standard stirring and heating protocol according to the manufacturer's instructions. Viscosity was measured in centipoise (cP).
Figure 13 shows the viscosity profiles of tuber starches from plants transformed with the antisense isoamylase construct. The linear plot shows the temperature profile. In addition a wild type control (line 1302, unbroken thin line) is shown. Starch from line 1352 (solid thick curve) shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level (lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line). In addition the viscosity onset temperature (pasting temperature) is slightly increased for line 1352. These data clearly indicate that the reduction of isoamylase activity (in line 1352) changes the starch strucmre and composition resulting in novel physico-chemical properties.
Discussion
When this work was started, no cDNA clones of potato debranching enzymes had been reported although some peptide sequences from a purified potato pullulanase were published in patent WO 95/04826. The present inventors were able to clone a partial length (672 bp) cDNA .clone of a potato pullulanase (pSJ98, Figure 10). A second publication (WO 96/19581) by the authors of WO 95/04826 then described the cloning of a full length cDNA of a spinach DBE (pullulanase type) as well as a PCR fragment of a potato pullulanase." The latter PCR fragment (492 bp) was isolated using primers derived from the sequence of a genomic clone which hybridised to a degenerate oligonucleotide very similar to the PDBEl oligo which was used in the experiments described here. However the deduced amino acid sequence of the PCR fragment did not correspond exactly to the two peptide sequences from the purified protein (RTLLVNLDSDDVKPEGGDNL, SEQ. ID. NO. 30; and RLSSAGITHVHLLPTYNFA, SEQ. ID. NO. 31; differences are shown underlined). The authors of WO 96/19581 concluded that this was a result of the protein being purified from the variety Desiree whereas the cDNA library was constructed from the variety Berolina. However, the peptide sequences also do not match exactly the sequence of pSJ98 (which was isolated from Desiree) suggesting that more than one pullulanase type DBE gene exists in potato. This is supported by the comparison the of the two PCR fragments which show only 93.6% identity at the DNA and 90.7% at the protein level with one amino acid insertion in the prior art clone (data not shown).
Further evidence that more than one pullulanase gene exists was provided by the cloning of two PCR fragments (1.8 and 1.6 kb) from genomic DNA (pSJ134 & 135). Sequence obtained from the ends of the clones indicated that they differed in the size of one intron (compare Figures 3A/B and 4A/B). The exon sequence of clone pSJ134 was identical to pSJ98 at the amino acid level but those of pSJ135 differed at one amino acid (results not shown).
The inventors have also cloned two PCR fragments (2.4 and 2.0 kb; pSJ133 and 137 respectively) from genomic DNA of potato which have significant homology to isoamylase genes. These clones differ in the size, and perhaps number, of introns and are about 96-97% identical (Figure 4), suggesting that they are derived from different genes. A cDNA fragment of approx 1500 bp was obtained by 3 'RACE; this cDNA encodes 429 aa which are 77% identical to the maize isoamylase gene and the inventors are confident that this gene is an isoamylase type DBE. It is possible that the two different isoamylase-type DBE genomic sequences isolated by the inventors relate to two different genes having slightly different functions or roles in the potato plant, and that similar multiple isoamylase-type genes exist in other plants. Different isoamylase-type genes might, for instance, be subjected- to different regulatory* controls. As the genomic sequences recovered are not full length genes, it is possible that the respective gene sequences may diverge in the uncloned portions. It may therefore be desirable to ensure that, in the various methods of the invention defined previously, a single sequence is used which is sufficiently long, and has sufficient homology to both isoamylase-type sequences that expression of both native isoamylase-type genes (if present) is inhibited, or, in the alternative, to ensure that two different sequences are employed to inhibit expression of the respective native isoamylase-type genes. The same comments apply equally to the pullulanase-type sequences discovered by the inventors.
Both pullulanase and isoamylase genes appear to be expressed in mbers and leaves since PCR bands of the correct size can be amplified from either mber or leaf first strand cDNA templates. The intensity of the amplified band is stronger in mbers for both DBE, possibly indicating that the expression level of both genes is higher in mbers, but this should be confirmed by northern analysis.
References
Ball et al., (1996) Cell 86, 349-352.
Becker et al., (1992) Plant Molecular Biology 20, 1195-1197.
Burton et al, (1995) Plant J. 7, 3-15.
Drummond et al, (1970) FEBS Lett 9, 136-140.
Frohman et al, (1988) Proc. Natl. Acad. Sci. USA 85, 8998-9002.
Gidley (1985) Carbohydrate Research 139, 85-93.
Guerineau et al, (1988) Nucl. Acids Res. 16, 11380.
Ishizaki et al, (1983) Agric. Biol. Chem. 47, 771-779.
James et al, (1995) Plant Cell 7, 417-429.
Jefferson et al, (1987) EMBO J. 6, 3901-3907.
Koømann et α/.,(1995) WO 95/04826.
Koβmann et al, (1996) WO 96/19581. Kortsee et al, (1996) The Plant Journal 10, 83-90.
Logemann et al, (1987) Anal. Biochem. 163, 21-26.
Molulle et al, (1996) Plant Cell 8,1353-1366.
Murray & Thompson (1980) Nucl. Acids Res. 8, 4321- 4325.
Nakamura (1996) Plant Science 121, 1-18.
Nakamura et al, (1996) Planta 199, 209-218.
Pan & Nelson (1984) Plant Physiol. 74, 324-328.
Renz et al, (1995) Genbank accession number X83969.
Sambrook et al, (1989) Molecular cloning: A laboratory manual, 2nd ed. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Tolmasky & Krisman (1987) Eur. J. Biochem. 168, 393-397.
Takeda et al, (1993) Carbohydrate Research 240, 253-263.
Visser et al, (1989) Plant Sci. 64, 185-192.

Claims

Claims
1. A nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene. - "
2. A sequence according to claim 1, comprising at least 200bp of an isoamylase gene.
3. A sequence according to claim 1 or 2, comprising at least 300-600bp of an isoamylase
4. A sequence according to any one of claims 1, 2 or 3, comprising substantially any one of the nucleic acid sequences shown in Figures 5A and 5B, or a functional equivalent thereof.
5. A sequence according to any one of claims 1, 2 or 3, comprising substantially any one of the nucleic acid sequences shown in Figures 6A, 6B, 7A and 7B, or a functional equivalent thereof.
6. A sequence according to any one of claims 1, 2 or 3 which, when linked in the sense orientation to a promoter, encodes a polypeptide comprising the amino acid sequence shown in Figure 8.
7. A sequence according to claim 6, comprising substantially nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8. or a functional equivalent thereof.
8. A nucleic acid construct comprising a sequence in accordance with any one of the preceding claims operably linked in the sense or antisense orientation to a promoter active in a plant.
9. A host cell into which has been introduced a sequence in accordance with any one of claims 1-7, or a construct in accordance with claim 8.
10. A plant cell according to claim 9.
1 1. A plantlet grown from a plant cell according to claim 10.
12. A method of altering a plant by inhibiting the expression of an isoamylase therein, the method comprising the steps of: introducing into the plant at least 200bp of a sequence carrying- an isoamylase gene and exhibiting at least 80% identity with a nucleic acid sequence shown in any one of Figures 5A, 5B, 6A, 6B, 7A, 7B or 8, said sequence being operably linked in the sense or antisense orientation to a suitable promoter active in the plant; and causing transcription of the introduced nucleic acid sequence, said transcript and/or the translation product thereof being sufficient to interfere with the expression of a homologous isoamylase gene naturally present in the plant.
13. A method according to claim 12, wherein the plant is: potato, sweet potato, maize, wheat, barley, oat, cassava, pea, or rice.
14. A method according to claim 12 or 13, comprising the introduction of one or more additional nucleic acid sequences, operably linked in the sense or anti-sense orientation to a suitable promoter active in the plant, and causing transcription of the one or more additional nucleic acid sequences, said transcript(s) and/or the translation product(s) thereof being sufficient to interfere with the expression of a homologous gene present in the plant.
15. A method according to claim 14, wherein said additional nucleic acid sequence comprises an effective portion of a pullulanase type debranching enzyme.
16. A method according to claim 14 or 15, wherein the said additional nucleic acid sequence comprises a portion which confers a waxy (i.e. low amylose starch) phenotype on the plant.
17. A method according to any one of claims 12-15, wherein the sequences are introduced into a plant having a waxy (i.e. low amylose starch) phenotype.
18. A method according to any one of claims 12-17, wherein the method results in a plant comprising starch having different properties compared to starch from an equivalent, but unaltered plant.
19. A plant altered by the method of any one of claims 12-18, or the progeny thereof.
20. Starch obtained from a plant according to claim 19, having altered properties compared to starch obtained from an equivalent but unaltered plant.
21. Starch according to claim 20. having increased branching and/or shorter chain length compared to starch extracted from an equivalent but unaltered plant.
22. Starch according to claim 19 or 20, having reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
23. Starch according to any one of claims 19, 20 or 21, having higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
24. Starch according to any one of claims 19-22, having an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
25. A nucleic acid sequence substantially as hereinbefore defined and with reference to the accompanying drawings.
26. A method of altering a plant substantially as hereinbefore defined.
PCT/GB1998/002665 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches WO1999012950A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002302639A CA2302639A1 (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches
AU89911/98A AU8991198A (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches
EP98941593A EP1009751A2 (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9718863.5 1997-09-06
GBGB9718863.5A GB9718863D0 (en) 1997-09-06 1997-09-06 Improvements in or relating to stability of plant starches

Publications (3)

Publication Number Publication Date
WO1999012950A2 true WO1999012950A2 (en) 1999-03-18
WO1999012950A3 WO1999012950A3 (en) 1999-05-06
WO1999012950A9 WO1999012950A9 (en) 1999-06-10

Family

ID=10818600

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1998/002665 WO1999012950A2 (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches

Country Status (5)

Country Link
EP (1) EP1009751A2 (en)
AU (1) AU8991198A (en)
CA (1) CA2302639A1 (en)
GB (1) GB9718863D0 (en)
WO (1) WO1999012950A2 (en)

Cited By (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469230B1 (en) 1997-07-31 2002-10-22 Plant Bioscience Limited Starch debranching enzymes
EP2039771A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2039772A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants introduction
EP2039770A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2072506A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide
EP2090168A1 (en) 2008-02-12 2009-08-19 Bayer CropScience AG Method for improving plant growth
EP2168434A1 (en) 2008-08-02 2010-03-31 Bayer CropScience AG Use of azols to increase resistance of plants of parts of plants to abiotic stress
EP2198709A1 (en) 2008-12-19 2010-06-23 Bayer CropScience AG Method for treating resistant animal pests
EP2201838A1 (en) 2008-12-05 2010-06-30 Bayer CropScience AG Active ingredient-beneficial organism combinations with insecticide and acaricide properties
EP2204094A1 (en) 2008-12-29 2010-07-07 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants Introduction
WO2010083955A2 (en) 2009-01-23 2010-07-29 Bayer Cropscience Aktiengesellschaft Use of enaminocarboxylic compounds for fighting viruses transmitted by insects
WO2010086095A1 (en) 2009-01-29 2010-08-05 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants introduction
WO2010086311A1 (en) 2009-01-28 2010-08-05 Bayer Cropscience Ag Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
EP2218717A1 (en) 2009-02-17 2010-08-18 Bayer CropScience AG Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
WO2010094666A2 (en) 2009-02-17 2010-08-26 Bayer Cropscience Ag Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
WO2010094728A1 (en) 2009-02-19 2010-08-26 Bayer Cropscience Ag Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
EP2223602A1 (en) 2009-02-23 2010-09-01 Bayer CropScience AG Method for improved utilisation of the production potential of genetically modified plants
EP2232995A1 (en) 2009-03-25 2010-09-29 Bayer CropScience AG Method for improved utilisation of the production potential of transgenic plants
EP2239331A1 (en) 2009-04-07 2010-10-13 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2251331A1 (en) 2009-05-15 2010-11-17 Bayer CropScience AG Fungicide pyrazole carboxamides derivatives
EP2255626A1 (en) 2009-05-27 2010-12-01 Bayer CropScience AG Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress
WO2011006603A2 (en) 2009-07-16 2011-01-20 Bayer Cropscience Ag Synergistic active substance combinations containing phenyl triazoles
WO2011015524A2 (en) 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
EP2292094A1 (en) 2009-09-02 2011-03-09 Bayer CropScience AG Active compound combinations
WO2011080256A1 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011080254A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011080255A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
EP2343280A1 (en) 2009-12-10 2011-07-13 Bayer CropScience AG Fungicide quinoline derivatives
WO2011089071A2 (en) 2010-01-22 2011-07-28 Bayer Cropscience Ag Acaricide and/or insecticide active substance combinations
WO2011107504A1 (en) 2010-03-04 2011-09-09 Bayer Cropscience Ag Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants
EP2374791A1 (en) 2008-08-14 2011-10-12 Bayer CropScience Aktiengesellschaft Insecticidal 4-phenyl-1H pyrazoles
WO2011124554A2 (en) 2010-04-06 2011-10-13 Bayer Cropscience Ag Use of 4-phenylbutyric acid and/or the salts thereof for enhancing the stress tolerance of plants
WO2011124553A2 (en) 2010-04-09 2011-10-13 Bayer Cropscience Ag Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress
WO2011134912A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011134913A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011134911A2 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011151369A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
WO2011151370A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues
WO2011151368A2 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
WO2011154158A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
WO2011154159A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
US8080688B2 (en) 2007-03-12 2011-12-20 Bayer Cropscience Ag 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides
WO2012010579A2 (en) 2010-07-20 2012-01-26 Bayer Cropscience Ag Benzocycloalkenes as antifungal agents
WO2012028578A1 (en) 2010-09-03 2012-03-08 Bayer Cropscience Ag Substituted fused pyrimidinones and dihydropyrimidinones
WO2012038480A2 (en) 2010-09-22 2012-03-29 Bayer Cropscience Ag Use of biological or chemical control agents for controlling insects and nematodes in resistant crops
WO2012045798A1 (en) 2010-10-07 2012-04-12 Bayer Cropscience Ag Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative
WO2012052489A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag 1-(heterocyclic carbonyl) piperidines
WO2012052490A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag N-benzyl heterocyclic carboxamides
US8168567B2 (en) 2007-04-19 2012-05-01 Bayer Cropscience Ag Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
WO2012059497A1 (en) 2010-11-02 2012-05-10 Bayer Cropscience Ag N-hetarylmethyl pyrazolylcarboxamides
WO2012065944A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag N-aryl pyrazole(thio)carboxamides
WO2012065945A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazole(thio)carboxamides
WO2012065947A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazolecarboxamides
EP2460407A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Agent combinations comprising pyridylethyl benzamides and other agents
EP2460406A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Use of fluopyram for controlling nematodes in nematode resistant crops
WO2012072660A1 (en) 2010-12-01 2012-06-07 Bayer Cropscience Ag Use of fluopyram for controlling nematodes in crops and for increasing yield
WO2012089722A2 (en) 2010-12-30 2012-07-05 Bayer Cropscience Ag Use of open-chain carboxylic acids, carbonic esters, carboxamides and carbonitriles of aryl, heteroaryl and benzylsulfonamide or the salts thereof for improving the stress tolerance in plants
WO2012089757A1 (en) 2010-12-29 2012-07-05 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
EP2474542A1 (en) 2010-12-29 2012-07-11 Bayer CropScience AG Fungicide hydroximoyl-tetrazole derivatives
EP2494867A1 (en) 2011-03-01 2012-09-05 Bayer CropScience AG Halogen-substituted compounds in combination with fungicides
WO2012120105A1 (en) 2011-03-10 2012-09-13 Bayer Cropscience Ag Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds
WO2012123434A1 (en) 2011-03-14 2012-09-20 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2012136581A1 (en) 2011-04-08 2012-10-11 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
US8288426B2 (en) 2006-12-22 2012-10-16 Bayer Cropscience Ag Pesticidal composition comprising fenamidone and an insecticide compound
EP2511255A1 (en) 2011-04-15 2012-10-17 Bayer CropScience AG Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
WO2012139891A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
WO2012139892A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)-penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)-pent-2-ene-4-ines as active agents against abiotic stress in plants
WO2012139890A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(cyclohex-2-en-1-yl)-penta-2,4-dienes and 5-(cyclohex-2-en-1-yl)-pent-2-en-4-ines as active agents against abiotic stress in plants
US8299302B2 (en) 2007-03-12 2012-10-30 Bayer Cropscience Ag 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides
WO2012168124A1 (en) 2011-06-06 2012-12-13 Bayer Cropscience Nv Methods and means to modify a plant genome at a preselected site
WO2013004652A1 (en) 2011-07-04 2013-01-10 Bayer Intellectual Property Gmbh Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
WO2013020985A1 (en) 2011-08-10 2013-02-14 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
EP2561759A1 (en) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
WO2013026836A1 (en) 2011-08-22 2013-02-28 Bayer Intellectual Property Gmbh Fungicide hydroximoyl-tetrazole derivatives
WO2013026740A2 (en) 2011-08-22 2013-02-28 Bayer Cropscience Nv Methods and means to modify a plant genome
US8394991B2 (en) 2007-03-12 2013-03-12 Bayer Cropscience Ag Phenoxy substituted phenylamidine derivatives and their use as fungicides
WO2013034621A1 (en) 2011-09-09 2013-03-14 Bayer Intellectual Property Gmbh Acyl-homoserine lactone derivatives for improving plant yield
WO2013037956A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of 5-phenyl- or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield
WO2013037958A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of phenylpyrazolin-3-carboxylates for improving plant yield
WO2013037955A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of acylsulfonamides for improving plant yield
WO2013037717A1 (en) 2011-09-12 2013-03-21 Bayer Intellectual Property Gmbh Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives
WO2013041602A1 (en) 2011-09-23 2013-03-28 Bayer Intellectual Property Gmbh Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
WO2013050410A1 (en) 2011-10-04 2013-04-11 Bayer Intellectual Property Gmbh RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
WO2013050324A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress
WO2013075817A1 (en) 2011-11-21 2013-05-30 Bayer Intellectual Property Gmbh Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
US8455480B2 (en) 2007-09-26 2013-06-04 Bayer Cropscience Ag Active agent combinations having insecticidal and acaricidal properties
WO2013079566A2 (en) 2011-11-30 2013-06-06 Bayer Intellectual Property Gmbh Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives
WO2013092519A1 (en) 2011-12-19 2013-06-27 Bayer Cropscience Ag Use of anthranilic acid diamide derivatives for pest control in transgenic crops
WO2013098146A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
WO2013098147A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
US8487118B2 (en) 2009-01-19 2013-07-16 Bayer Cropscience Ag Cyclic diones and their use as insecticides, acaricides and/or fungicides
WO2013124275A1 (en) 2012-02-22 2013-08-29 Bayer Cropscience Ag Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape.
WO2013127704A1 (en) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Active compound combinations containing a thiazoylisoxazoline and a fungicide
WO2013139949A1 (en) 2012-03-23 2013-09-26 Bayer Intellectual Property Gmbh Compositions comprising a strigolactame compound for enhanced plant growth and yield
WO2013153143A1 (en) 2012-04-12 2013-10-17 Bayer Cropscience Ag N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides
WO2013156560A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives
WO2013156559A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2013160230A1 (en) 2012-04-23 2013-10-31 Bayer Cropscience Nv Targeted genome engineering in plants
EP2662361A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazol indanyl carboxamides
EP2662364A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole tetrahydronaphthyl carboxamides
EP2662362A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole indanyl carboxamides
EP2662363A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole biphenylcarboxamides
EP2662370A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole benzofuranyl carboxamides
EP2662360A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole indanyl carboxamides
WO2013167544A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag 5-halogenopyrazole indanyl carboxamides
WO2013167545A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag Pyrazole indanyl carboxamides
WO2013174836A1 (en) 2012-05-22 2013-11-28 Bayer Cropscience Ag Active compounds combinations comprising a lipo-chitooligosaccharide derivative and a nematicide, insecticidal or fungicidal compound
WO2014009322A1 (en) 2012-07-11 2014-01-16 Bayer Cropscience Ag Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress
WO2014037340A1 (en) 2012-09-05 2014-03-13 Bayer Cropscience Ag Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
WO2014060520A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives
WO2014060502A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Active compound combinations comprising carboxamide derivatives
WO2014060518A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method of plant growth promotion using carboxamide derivatives
WO2014060519A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives
EP2735231A1 (en) 2012-11-23 2014-05-28 Bayer CropScience AG Active compound combinations
WO2014079957A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Selective inhibition of ethylene signal transduction
WO2014083089A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal and pesticidal mixtures
WO2014083088A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary fungicidal mixtures
WO2014082950A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal mixtures
WO2014083033A1 (en) 2012-11-30 2014-06-05 Bayer Cropsience Ag Binary fungicidal or pesticidal mixture
WO2014083031A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary pesticidal and fungicidal mixtures
EP2740356A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
EP2740720A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
WO2014086751A1 (en) 2012-12-05 2014-06-12 Bayer Cropscience Ag Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
WO2014090765A1 (en) 2012-12-12 2014-06-19 Bayer Cropscience Ag Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops
WO2014095677A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides
WO2014095826A1 (en) 2012-12-18 2014-06-26 Bayer Cropscience Ag Binary fungicidal and bactericidal combinations
US8785692B2 (en) 2007-03-12 2014-07-22 Bayer Cropscience Ag Substituted phenylamidines and the use thereof as fungicides
US8796175B2 (en) 2008-08-29 2014-08-05 Bayer Cropscience Ag Method for enhancing plant intrinsic defense
US8828906B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8828907B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active ingredient combinations having insecticidal and acaricidal properties
WO2014135608A1 (en) 2013-03-07 2014-09-12 Bayer Cropscience Ag Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives
US8835657B2 (en) 2009-05-06 2014-09-16 Bayer Cropscience Ag Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides
US8846567B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8846568B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
WO2014161821A1 (en) 2013-04-02 2014-10-09 Bayer Cropscience Nv Targeted genome engineering in eukaryotes
WO2014167009A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
WO2014170364A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Binary insecticidal or pesticidal mixture
WO2014170345A2 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants
WO2014177514A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag Nematicidal n-substituted phenethylcarboxamides
WO2014177582A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides
WO2014206953A1 (en) 2013-06-26 2014-12-31 Bayer Cropscience Ag N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives
US8927583B2 (en) 2006-12-22 2015-01-06 Bayer Cropscience Ag Pesticidal composition comprising a 2-pyrdilmethylbenzamide derivative and an insecticide compound
WO2015004040A1 (en) 2013-07-09 2015-01-15 Bayer Cropscience Ag Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
US9012360B2 (en) 2009-03-25 2015-04-21 Bayer Intellectual Property Gmbh Synergistic combinations of active ingredients
WO2015082586A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
WO2015082587A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
US9199922B2 (en) 2007-03-12 2015-12-01 Bayer Intellectual Property Gmbh Dihalophenoxyphenylamidines and use thereof as fungicides
US9232794B2 (en) 2009-06-02 2016-01-12 Bayer Intellectual Property Gmbh Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp
WO2016012362A1 (en) 2014-07-22 2016-01-28 Bayer Cropscience Aktiengesellschaft Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress
EP2997825A1 (en) 2011-04-22 2016-03-23 Bayer Intellectual Property GmbH Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
EP3000809A1 (en) 2009-05-15 2016-03-30 Bayer Intellectual Property GmbH Fungicide pyrazole carboxamides derivatives
WO2016096942A1 (en) 2014-12-18 2016-06-23 Bayer Cropscience Aktiengesellschaft Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
WO2016166077A1 (en) 2015-04-13 2016-10-20 Bayer Cropscience Aktiengesellschaft N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives
US9763451B2 (en) 2008-12-29 2017-09-19 Bayer Intellectual Property Gmbh Method for improved use of the production potential of genetically modified plants
WO2018019676A1 (en) 2016-07-29 2018-02-01 Bayer Cropscience Aktiengesellschaft Active compound combinations and methods to protect the propagation material of plants
WO2018054911A1 (en) 2016-09-23 2018-03-29 Bayer Cropscience Nv Targeted genome optimization in plants
WO2018054832A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
WO2018054829A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives and their use as fungicides
WO2018077711A2 (en) 2016-10-26 2018-05-03 Bayer Cropscience Aktiengesellschaft Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications
EP3332645A1 (en) 2016-12-12 2018-06-13 Bayer Cropscience AG Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress
WO2018104392A1 (en) 2016-12-08 2018-06-14 Bayer Cropscience Aktiengesellschaft Use of insecticides for controlling wireworms
WO2018108627A1 (en) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
DE102007045953B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
WO2019025153A1 (en) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants
WO2019060746A1 (en) 2017-09-21 2019-03-28 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
WO2019233863A1 (en) 2018-06-04 2019-12-12 Bayer Aktiengesellschaft Herbicidally active bicyclic benzoylpyrazoles
WO2020131862A1 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof
US10968257B2 (en) 2018-04-03 2021-04-06 The Broad Institute, Inc. Target recognition motifs and uses thereof
US11180751B2 (en) 2015-06-18 2021-11-23 The Broad Institute, Inc. CRISPR enzymes and systems
US11591601B2 (en) 2017-05-05 2023-02-28 The Broad Institute, Inc. Methods for identification and modification of lncRNA associated with target genotypes and phenotypes

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007045922A1 (en) 2007-09-26 2009-04-02 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004826A1 (en) * 1993-08-09 1995-02-16 Institut Für Genbiologische Forschung Berlin Gmbh Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants
WO1996003513A2 (en) * 1994-07-28 1996-02-08 Monsanto Company Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it
WO1996019581A1 (en) * 1994-12-22 1996-06-27 Hoechst Schering Agrevo Gmbh Dna molecules coding for debranching enzymes derived from plants
WO1997042328A1 (en) * 1996-05-06 1997-11-13 Planttec Biotechnologie Gmbh Nucleic acid molecules which code the potato debranching enzyme
WO1999006575A1 (en) * 1997-07-31 1999-02-11 Plant Bioscience Limited Starch debranching enzymes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004826A1 (en) * 1993-08-09 1995-02-16 Institut Für Genbiologische Forschung Berlin Gmbh Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants
WO1996003513A2 (en) * 1994-07-28 1996-02-08 Monsanto Company Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it
WO1996019581A1 (en) * 1994-12-22 1996-06-27 Hoechst Schering Agrevo Gmbh Dna molecules coding for debranching enzymes derived from plants
WO1997042328A1 (en) * 1996-05-06 1997-11-13 Planttec Biotechnologie Gmbh Nucleic acid molecules which code the potato debranching enzyme
WO1999006575A1 (en) * 1997-07-31 1999-02-11 Plant Bioscience Limited Starch debranching enzymes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ISHIZAKI Y ET AL: "DEBRANCHING ENZYMES OF POTATO TUBERS (SOLANUM TUBEROSUM L.) I PURIFICATION AND SOME PROPERTIES OF POTATO ISOMYLASE" AGRICULTURAL AND BIOLOGICAL CHEMISTRY, vol. 47, no. 4, 1 January 1983, pages 771-779, XP002001115 *
KORTSTEE ET AL: "Expression of Escherichia coli branching enzyme in tubers of amylose-free transgenic potato leads to an increased branching degree of the amylopectin" PLANT JOURNAL, vol. 10, no. 1, 1996, pages 83-90, XP002084156 cited in the application *
SHEWMAKER C K ET AL: "EXPRESSION OF ESCHERICHIA COLI GLYCOGEN SYNTHASE IN THE TUBERS OF TRANSGENIC POTATOES (SOLANUM TUBEROSUM) RESULTS IN A HIGHLY BRANCHED STARCH" PLANT PHYSIOLOGY, vol. 104, 1994, pages 1159-1166, XP002033871 *

Cited By (192)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469230B1 (en) 1997-07-31 2002-10-22 Plant Bioscience Limited Starch debranching enzymes
US8288426B2 (en) 2006-12-22 2012-10-16 Bayer Cropscience Ag Pesticidal composition comprising fenamidone and an insecticide compound
US8927583B2 (en) 2006-12-22 2015-01-06 Bayer Cropscience Ag Pesticidal composition comprising a 2-pyrdilmethylbenzamide derivative and an insecticide compound
US8299302B2 (en) 2007-03-12 2012-10-30 Bayer Cropscience Ag 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides
US8394991B2 (en) 2007-03-12 2013-03-12 Bayer Cropscience Ag Phenoxy substituted phenylamidine derivatives and their use as fungicides
US8080688B2 (en) 2007-03-12 2011-12-20 Bayer Cropscience Ag 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides
US8785692B2 (en) 2007-03-12 2014-07-22 Bayer Cropscience Ag Substituted phenylamidines and the use thereof as fungicides
US8748662B2 (en) 2007-03-12 2014-06-10 Bayer Cropscience Ag 4-cycloalkyl or 4-aryl substituted phenoxyphenylamidines and use thereof as fungicides
US9199922B2 (en) 2007-03-12 2015-12-01 Bayer Intellectual Property Gmbh Dihalophenoxyphenylamidines and use thereof as fungicides
US8168567B2 (en) 2007-04-19 2012-05-01 Bayer Cropscience Ag Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
US8455480B2 (en) 2007-09-26 2013-06-04 Bayer Cropscience Ag Active agent combinations having insecticidal and acaricidal properties
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
DE102007045953B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
EP2072506A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide
EP2090168A1 (en) 2008-02-12 2009-08-19 Bayer CropScience AG Method for improving plant growth
EP2168434A1 (en) 2008-08-02 2010-03-31 Bayer CropScience AG Use of azols to increase resistance of plants of parts of plants to abiotic stress
EP2374791A1 (en) 2008-08-14 2011-10-12 Bayer CropScience Aktiengesellschaft Insecticidal 4-phenyl-1H pyrazoles
US8796175B2 (en) 2008-08-29 2014-08-05 Bayer Cropscience Ag Method for enhancing plant intrinsic defense
EP2201838A1 (en) 2008-12-05 2010-06-30 Bayer CropScience AG Active ingredient-beneficial organism combinations with insecticide and acaricide properties
EP2198709A1 (en) 2008-12-19 2010-06-23 Bayer CropScience AG Method for treating resistant animal pests
WO2010075994A1 (en) 2008-12-29 2010-07-08 Bayer Cropscience Aktiengesellschaft Treatment of transgenic crops with mixtures of fiproles and chloronicotinyls
EP2204094A1 (en) 2008-12-29 2010-07-07 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants Introduction
US9763451B2 (en) 2008-12-29 2017-09-19 Bayer Intellectual Property Gmbh Method for improved use of the production potential of genetically modified plants
EP2039770A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2039772A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants introduction
EP2039771A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
US8487118B2 (en) 2009-01-19 2013-07-16 Bayer Cropscience Ag Cyclic diones and their use as insecticides, acaricides and/or fungicides
EP2227951A1 (en) 2009-01-23 2010-09-15 Bayer CropScience AG Application of enaminocarbonyl compounds for combating viruses transmitted by insects
WO2010083955A2 (en) 2009-01-23 2010-07-29 Bayer Cropscience Aktiengesellschaft Use of enaminocarboxylic compounds for fighting viruses transmitted by insects
WO2010086311A1 (en) 2009-01-28 2010-08-05 Bayer Cropscience Ag Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
WO2010086095A1 (en) 2009-01-29 2010-08-05 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants introduction
EP2218717A1 (en) 2009-02-17 2010-08-18 Bayer CropScience AG Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
WO2010094666A2 (en) 2009-02-17 2010-08-26 Bayer Cropscience Ag Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
WO2010094728A1 (en) 2009-02-19 2010-08-26 Bayer Cropscience Ag Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
EP2223602A1 (en) 2009-02-23 2010-09-01 Bayer CropScience AG Method for improved utilisation of the production potential of genetically modified plants
US9012360B2 (en) 2009-03-25 2015-04-21 Bayer Intellectual Property Gmbh Synergistic combinations of active ingredients
US8846568B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8846567B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
EP2232995A1 (en) 2009-03-25 2010-09-29 Bayer CropScience AG Method for improved utilisation of the production potential of transgenic plants
US8828907B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active ingredient combinations having insecticidal and acaricidal properties
US8828906B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
EP2239331A1 (en) 2009-04-07 2010-10-13 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
US8835657B2 (en) 2009-05-06 2014-09-16 Bayer Cropscience Ag Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides
EP2251331A1 (en) 2009-05-15 2010-11-17 Bayer CropScience AG Fungicide pyrazole carboxamides derivatives
EP3000809A1 (en) 2009-05-15 2016-03-30 Bayer Intellectual Property GmbH Fungicide pyrazole carboxamides derivatives
EP2255626A1 (en) 2009-05-27 2010-12-01 Bayer CropScience AG Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress
US9232794B2 (en) 2009-06-02 2016-01-12 Bayer Intellectual Property Gmbh Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp
US9877482B2 (en) 2009-06-02 2018-01-30 Bayer Intellectual Property Gmbh Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp
WO2011006603A2 (en) 2009-07-16 2011-01-20 Bayer Cropscience Ag Synergistic active substance combinations containing phenyl triazoles
WO2011015524A2 (en) 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
EP2292094A1 (en) 2009-09-02 2011-03-09 Bayer CropScience AG Active compound combinations
WO2011035834A1 (en) 2009-09-02 2011-03-31 Bayer Cropscience Ag Active compound combinations
EP2343280A1 (en) 2009-12-10 2011-07-13 Bayer CropScience AG Fungicide quinoline derivatives
WO2011080256A1 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011080255A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011080254A2 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011089071A2 (en) 2010-01-22 2011-07-28 Bayer Cropscience Ag Acaricide and/or insecticide active substance combinations
US8722072B2 (en) 2010-01-22 2014-05-13 Bayer Intellectual Property Gmbh Acaricidal and/or insecticidal active ingredient combinations
WO2011107504A1 (en) 2010-03-04 2011-09-09 Bayer Cropscience Ag Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants
WO2011124554A2 (en) 2010-04-06 2011-10-13 Bayer Cropscience Ag Use of 4-phenylbutyric acid and/or the salts thereof for enhancing the stress tolerance of plants
WO2011124553A2 (en) 2010-04-09 2011-10-13 Bayer Cropscience Ag Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress
WO2011134913A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011134911A2 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2011134912A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011151370A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues
WO2011151368A2 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
WO2011151369A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
WO2011154159A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
WO2011154158A1 (en) 2010-06-09 2011-12-15 Bayer Bioscience N.V. Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
WO2012010579A2 (en) 2010-07-20 2012-01-26 Bayer Cropscience Ag Benzocycloalkenes as antifungal agents
WO2012028578A1 (en) 2010-09-03 2012-03-08 Bayer Cropscience Ag Substituted fused pyrimidinones and dihydropyrimidinones
WO2012038480A2 (en) 2010-09-22 2012-03-29 Bayer Cropscience Ag Use of biological or chemical control agents for controlling insects and nematodes in resistant crops
WO2012038476A1 (en) 2010-09-22 2012-03-29 Bayer Cropscience Ag Use of active ingredients for controlling nematodes in nematode-resistant crops
WO2012045798A1 (en) 2010-10-07 2012-04-12 Bayer Cropscience Ag Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative
WO2012052489A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag 1-(heterocyclic carbonyl) piperidines
WO2012052490A1 (en) 2010-10-21 2012-04-26 Bayer Cropscience Ag N-benzyl heterocyclic carboxamides
WO2012059497A1 (en) 2010-11-02 2012-05-10 Bayer Cropscience Ag N-hetarylmethyl pyrazolylcarboxamides
WO2012065947A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazolecarboxamides
WO2012065944A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag N-aryl pyrazole(thio)carboxamides
US9206137B2 (en) 2010-11-15 2015-12-08 Bayer Intellectual Property Gmbh N-Aryl pyrazole(thio)carboxamides
WO2012065945A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazole(thio)carboxamides
WO2012072696A1 (en) 2010-12-01 2012-06-07 Bayer Cropscience Ag Active ingredient combinations comprising pyridylethylbenzamides and other active ingredients
EP3103339A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
EP3103338A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
EP3103340A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
EP3103334A1 (en) 2010-12-01 2016-12-14 Bayer Intellectual Property GmbH Agent combinations comprising pyridylethyl benzamides and other agents
EP3092900A1 (en) 2010-12-01 2016-11-16 Bayer Intellectual Property GmbH Active ingredient combinations comprising pyridylethylbenzamides and other active ingredients
WO2012072660A1 (en) 2010-12-01 2012-06-07 Bayer Cropscience Ag Use of fluopyram for controlling nematodes in crops and for increasing yield
EP2460406A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Use of fluopyram for controlling nematodes in nematode resistant crops
EP2460407A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Agent combinations comprising pyridylethyl benzamides and other agents
EP2474542A1 (en) 2010-12-29 2012-07-11 Bayer CropScience AG Fungicide hydroximoyl-tetrazole derivatives
WO2012089757A1 (en) 2010-12-29 2012-07-05 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2012089722A2 (en) 2010-12-30 2012-07-05 Bayer Cropscience Ag Use of open-chain carboxylic acids, carbonic esters, carboxamides and carbonitriles of aryl, heteroaryl and benzylsulfonamide or the salts thereof for improving the stress tolerance in plants
WO2012089721A1 (en) 2010-12-30 2012-07-05 Bayer Cropscience Ag Use of substituted spirocyclic sulfonamidocarboxylic acids, carboxylic esters thereof, carboxamides thereof and carbonitriles thereof or salts thereof for enhancement of stress tolerance in plants
EP2494867A1 (en) 2011-03-01 2012-09-05 Bayer CropScience AG Halogen-substituted compounds in combination with fungicides
WO2012120105A1 (en) 2011-03-10 2012-09-13 Bayer Cropscience Ag Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds
WO2012123434A1 (en) 2011-03-14 2012-09-20 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
WO2012136581A1 (en) 2011-04-08 2012-10-11 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
EP2511255A1 (en) 2011-04-15 2012-10-17 Bayer CropScience AG Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
WO2012139891A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
WO2012139892A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)-penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)-pent-2-ene-4-ines as active agents against abiotic stress in plants
WO2012139890A1 (en) 2011-04-15 2012-10-18 Bayer Cropscience Ag Substituted 5-(cyclohex-2-en-1-yl)-penta-2,4-dienes and 5-(cyclohex-2-en-1-yl)-pent-2-en-4-ines as active agents against abiotic stress in plants
EP2997825A1 (en) 2011-04-22 2016-03-23 Bayer Intellectual Property GmbH Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
WO2012168124A1 (en) 2011-06-06 2012-12-13 Bayer Cropscience Nv Methods and means to modify a plant genome at a preselected site
WO2013004652A1 (en) 2011-07-04 2013-01-10 Bayer Intellectual Property Gmbh Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
WO2013020985A1 (en) 2011-08-10 2013-02-14 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
US9265252B2 (en) 2011-08-10 2016-02-23 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
WO2013026836A1 (en) 2011-08-22 2013-02-28 Bayer Intellectual Property Gmbh Fungicide hydroximoyl-tetrazole derivatives
US10538774B2 (en) 2011-08-22 2020-01-21 Basf Agricultural Solutions Seed, Us Llc Methods and means to modify a plant genome
WO2013026740A2 (en) 2011-08-22 2013-02-28 Bayer Cropscience Nv Methods and means to modify a plant genome
US9670496B2 (en) 2011-08-22 2017-06-06 Bayer Cropscience N.V. Methods and means to modify a plant genome
EP2561759A1 (en) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
WO2013034621A1 (en) 2011-09-09 2013-03-14 Bayer Intellectual Property Gmbh Acyl-homoserine lactone derivatives for improving plant yield
WO2013037717A1 (en) 2011-09-12 2013-03-21 Bayer Intellectual Property Gmbh Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives
WO2013037955A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of acylsulfonamides for improving plant yield
WO2013037958A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of phenylpyrazolin-3-carboxylates for improving plant yield
WO2013037956A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of 5-phenyl- or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield
WO2013041602A1 (en) 2011-09-23 2013-03-28 Bayer Intellectual Property Gmbh Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
WO2013050410A1 (en) 2011-10-04 2013-04-11 Bayer Intellectual Property Gmbh RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
WO2013050324A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress
WO2013075817A1 (en) 2011-11-21 2013-05-30 Bayer Intellectual Property Gmbh Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
WO2013079566A2 (en) 2011-11-30 2013-06-06 Bayer Intellectual Property Gmbh Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives
WO2013092519A1 (en) 2011-12-19 2013-06-27 Bayer Cropscience Ag Use of anthranilic acid diamide derivatives for pest control in transgenic crops
WO2013098147A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
WO2013098146A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
WO2013124275A1 (en) 2012-02-22 2013-08-29 Bayer Cropscience Ag Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape.
WO2013127704A1 (en) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Active compound combinations containing a thiazoylisoxazoline and a fungicide
WO2013139949A1 (en) 2012-03-23 2013-09-26 Bayer Intellectual Property Gmbh Compositions comprising a strigolactame compound for enhanced plant growth and yield
WO2013153143A1 (en) 2012-04-12 2013-10-17 Bayer Cropscience Ag N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides
WO2013156559A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2013156560A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives
WO2013160230A1 (en) 2012-04-23 2013-10-31 Bayer Cropscience Nv Targeted genome engineering in plants
EP2662361A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazol indanyl carboxamides
EP2662364A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole tetrahydronaphthyl carboxamides
EP2662362A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole indanyl carboxamides
EP2662363A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole biphenylcarboxamides
EP2662370A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole benzofuranyl carboxamides
EP2662360A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole indanyl carboxamides
WO2013167544A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag 5-halogenopyrazole indanyl carboxamides
WO2013167545A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag Pyrazole indanyl carboxamides
WO2013174836A1 (en) 2012-05-22 2013-11-28 Bayer Cropscience Ag Active compounds combinations comprising a lipo-chitooligosaccharide derivative and a nematicide, insecticidal or fungicidal compound
WO2014009322A1 (en) 2012-07-11 2014-01-16 Bayer Cropscience Ag Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress
WO2014037340A1 (en) 2012-09-05 2014-03-13 Bayer Cropscience Ag Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
WO2014060518A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method of plant growth promotion using carboxamide derivatives
WO2014060520A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives
WO2014060519A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives
WO2014060502A1 (en) 2012-10-19 2014-04-24 Bayer Cropscience Ag Active compound combinations comprising carboxamide derivatives
WO2014079957A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Selective inhibition of ethylene signal transduction
EP2735231A1 (en) 2012-11-23 2014-05-28 Bayer CropScience AG Active compound combinations
WO2014079789A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Active compound combinations
WO2014083089A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal and pesticidal mixtures
WO2014083033A1 (en) 2012-11-30 2014-06-05 Bayer Cropsience Ag Binary fungicidal or pesticidal mixture
WO2014083031A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary pesticidal and fungicidal mixtures
WO2014083088A2 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary fungicidal mixtures
WO2014082950A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal mixtures
EP2740356A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
WO2014086751A1 (en) 2012-12-05 2014-06-12 Bayer Cropscience Ag Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
EP2740720A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
WO2014090765A1 (en) 2012-12-12 2014-06-19 Bayer Cropscience Ag Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops
WO2014095826A1 (en) 2012-12-18 2014-06-26 Bayer Cropscience Ag Binary fungicidal and bactericidal combinations
WO2014095677A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides
WO2014135608A1 (en) 2013-03-07 2014-09-12 Bayer Cropscience Ag Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives
WO2014161821A1 (en) 2013-04-02 2014-10-09 Bayer Cropscience Nv Targeted genome engineering in eukaryotes
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
WO2014167009A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazole derivatives
WO2014170345A2 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants
WO2014170364A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Binary insecticidal or pesticidal mixture
WO2014177514A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag Nematicidal n-substituted phenethylcarboxamides
WO2014177582A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides
WO2014206953A1 (en) 2013-06-26 2014-12-31 Bayer Cropscience Ag N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2015004040A1 (en) 2013-07-09 2015-01-15 Bayer Cropscience Ag Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
WO2015082587A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
WO2015082586A1 (en) 2013-12-05 2015-06-11 Bayer Cropscience Ag N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
WO2016012362A1 (en) 2014-07-22 2016-01-28 Bayer Cropscience Aktiengesellschaft Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress
WO2016096942A1 (en) 2014-12-18 2016-06-23 Bayer Cropscience Aktiengesellschaft Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
WO2016166077A1 (en) 2015-04-13 2016-10-20 Bayer Cropscience Aktiengesellschaft N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives
US11180751B2 (en) 2015-06-18 2021-11-23 The Broad Institute, Inc. CRISPR enzymes and systems
WO2018019676A1 (en) 2016-07-29 2018-02-01 Bayer Cropscience Aktiengesellschaft Active compound combinations and methods to protect the propagation material of plants
WO2018054832A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
WO2018054829A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives and their use as fungicides
WO2018054911A1 (en) 2016-09-23 2018-03-29 Bayer Cropscience Nv Targeted genome optimization in plants
WO2018077711A2 (en) 2016-10-26 2018-05-03 Bayer Cropscience Aktiengesellschaft Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications
WO2018104392A1 (en) 2016-12-08 2018-06-14 Bayer Cropscience Aktiengesellschaft Use of insecticides for controlling wireworms
EP3332645A1 (en) 2016-12-12 2018-06-13 Bayer Cropscience AG Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress
WO2018108627A1 (en) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
US11591601B2 (en) 2017-05-05 2023-02-28 The Broad Institute, Inc. Methods for identification and modification of lncRNA associated with target genotypes and phenotypes
WO2019025153A1 (en) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants
WO2019060746A1 (en) 2017-09-21 2019-03-28 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
US10968257B2 (en) 2018-04-03 2021-04-06 The Broad Institute, Inc. Target recognition motifs and uses thereof
WO2019233863A1 (en) 2018-06-04 2019-12-12 Bayer Aktiengesellschaft Herbicidally active bicyclic benzoylpyrazoles
WO2020131862A1 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Also Published As

Publication number Publication date
WO1999012950A3 (en) 1999-05-06
WO1999012950A9 (en) 1999-06-10
EP1009751A2 (en) 2000-06-21
GB9718863D0 (en) 1997-11-12
AU8991198A (en) 1999-03-29
CA2302639A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
EP1009751A2 (en) Improvements in or relating to stability of plant starches
US6956148B1 (en) Nucleic acids from cassava encoding starch branching enzyme II (SBEII) and their use
Woolley et al. Purification and properties of an endo-β-1, 4-glucanase from strawberry and down-regulation of the corresponding gene, cel1
AU724942B2 (en) Transgenic potatoes having reduced levels of alpha glucan L- or H-type tuber phosphorylase activity with reduced cold-sweetening
US6784338B1 (en) Genetically engineered modification of potato to form amylopectin-type starch
US6570066B1 (en) Nucleotide sequences encoding enzymes that alter the carbohydrate concentration and composition in plants
EP0719338B1 (en) Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants
CA2303407C (en) Regulation of gene expression in plants
US5750876A (en) Isoamylase gene, compositions containing it, and methods of using isoamylases
Wang et al. The essential role of GhPEL gene, encoding a pectate lyase, in cell wall loosening by depolymerization of the de-esterified pectin during fiber elongation in cotton
JP2002518015A (en) Improvement of or related to plants and plant products
EP0563201A1 (en) Genetically engineered modification of potato to form amylose-type starch
CA2136828A1 (en) Dna sequences and plasmids for the preparation of plants with changed sucrose concentration
US5767364A (en) Endo-1,4-beta-D-glucanase
HUT73468A (en) Method of improving the quality of stored potatoes
US5856467A (en) Genetically engineered modification of potato to form amylose-type starch
US5569829A (en) Transformed tomato plants
CA2529455A1 (en) Plant limit dextrinase inhibitor
AU727294B2 (en) Regulation of gene expression in plants
KR20050018626A (en) COFFEE PLANT WITH REDUCED α-D-GALACTOSIDASE ACTIVITY

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C2

Designated state(s): AU CA US

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1-18, SEQUENCE LISTING, ADDED

WWE Wipo information: entry into national phase

Ref document number: 1998941593

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 89911/98

Country of ref document: AU

ENP Entry into the national phase in:

Ref country code: CA

Ref document number: 2302639

Kind code of ref document: A

Format of ref document f/p: F

Ref document number: 2302639

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1998941593

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1998941593

Country of ref document: EP